2024

1. Aldy K, Krotulski A, Brent J, Campleman S, Culbreth R, Logan B, Wax P, Amaducci A, Judge B, Levine M, Schwarz E, Calello DP, Meaden CW, Shulman J, Hughes A, Hendrickson R, Carpenter J, Buchanan J, Manini A; On behalf of the ToxIC Fentalog Group. Emergency Department Patients with Para-Fluorofentanyl Overdose. J Emerg Med. 2024; Article in Press. View Publication

2. Brent J, Wax P, Culbreth R, Campleman S, Aldy K. From Patient Registry to Multi-Center Research Consortium: the Toxicology Investigators Consortium (ToxIC) Turns Fifteen. J Med Toxicol. 2024;20(3):293-298. View Publication

3. Culbreth R, Wax P, Brent J, Aldy K, Campleman S, Weiss S, Falise A, Sutphin A, Krotulski A, Manini A; On behalf of the ToxIC Fentalog Group. Factors Associated with Attempted Suicide Among Emergency Department Patients with Nonfatal Opioid Overdose. Substance Use & Misuse. 2024; doi.org/10.1080. View Publication

4. Glidden E, Gladden M, Dion C, Spyres M, Seth P, Aldy K, Mustaquim D; On behalf of the Toxicology Investigators Consortium (ToxIC). Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital — Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017–2022. MMWR Morb Mortal Wkly Rep. 2024;73(29):642-647. View Publication

5. Hughes A, Amaducci A, Campleman S, Li S, Costantini M, Spyres M, Spungen H, Kent J, Falise A, Culbreth R, Wax P, Brent J, Aldy K; On behalf of The Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium 2023 Annual Report. J Med Toxicol. 2024;20(3):350-380. View Publication

6. Levine M, Culbreth R, Amaducci A, Calello D, Shulman J, Judge B, Love J, Hughes A, Schwarz E, Carpenter J, Wax P, Aldy K, Krotulski A, Logan B, Buchanan J, Brent J, Meaden C, Hendrickson R, Abston S, Li S, Campleman S, Manini A; On behalf of the ToxIC Fentalog Study Group. Prevalence and predictors of HIV among patients presenting to US emergency departments with opioid overdose. Drug Alcohol Depend. 2024;264:112423. View Publication

7. Magnussan K, Glidden E, Mustaquim D, Welder L, Stokes E, Beauchamp G, Greenberg M, Aldy K, Mazzaccaro R, Careyva B, Sabino J, Fiske D, McLain K, Amaducci A; On behalf of the Toxicology Investigators Consortium (ToxIC). Differences in Drug Poisonings Among Those Who Identify as Transgender Compared to Cisgender: An Analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry, United States 2017–2021. Clin Ther. 2024; doi.org/10.1016. View Publication

8. Schimmel J, Epperson L, Aldy K, Wax P, Brent J, Bucahnan J, Levine M, Burkhart K; On behalf of the ToxIC FACT Study Group. Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. Drugs. 2024;84(2):209-217. View Publication

9. Schwarz E, Buchanan J, Aldy K, Shulman J, Krotulski A, Walton S, Logan B, Wax P, Campleman S, Brent J, Culbreth R, Manini A; On behalf of the ToxIC Fentalog Study Group. Notes from the Field: Detection of Medetomidine Among Patients Evaluated in Emergency Departments for Suspected Opioid Overdoses — Missouri, Colorado, and Pennsylvania, September 2020–December 2023. MMWR Morb Mortal Wkly Rep. 2024;73(30):672–674. View Publication

10. Shastry S, Lin J, Aldy K, Brent J, Wax P, Krotulski A, Campleman S, Li S, Meyn A, Abston S, Logan B, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Hughes A, Culbreth R, Schwarz E, Manini A; On behalf of the ToxIC Fentalog Study Group. Heroin or fentanyl: Prevalence of confirmed fentanyl in ED patients with suspected heroin overdose. J Am Coll Emerg Physicians Open. 2024;5(4):e13235. View Publication

11. Shastry S, Shulman J, Aldy K, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Psychostimulant Drug Co-ingestion in Non-Fatal Opioid Overdose. Drug Alcohol Depend Rep. 2024;10:100223. View Publication

12. Simon M, Kaplan S, Muschler K, Hoyte C, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The role of QRS complex prolongation in predicting severe toxicity in single-xenobiotic overdose. Clin Toxicol (Phila). 2024;62(1):32-38. View Publication

13. Simpson M, Campleman S, Brent J, Wax P, Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC). Predicting adverse cardiovascular events in emergency department patients with bupropion overdose. Acad Emerg Med. 2024;10.1111/acem.14960. View Publication

14. Tang K, Simpson M, Burns M; On behalf of the Toxicology Investigators Consortium (ToxIC). Evolving trends of pharmaceutical poisonings associated with QRS complex prolongation. Clin Toxicol (Phila). 2024;62(9):574-582. View Publication

15. Weiss ST, Li Xiaobai, Aldy K, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Self-Harm as a Contributor to the Opioid Epidemic: Data From the Toxicology Investigators Consortium Registry. J Addict Med. 2024; Article in Press. View Publication

2023

1. Amaducci A, Aldy K, Campleman S, Li S, Meyn A, Abston S, Culbreth R, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients. JAMA Netw Open. 2023;6(8):e2331264. View Publication

2. Amaducci A, Campleman S, Li S, Karshenas D, Spryes M, Farrugia L, Kang M, Culbreth R, Wax P, Brent J, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium 2022 Annual Report. J Med Toxicol. 2023;19(4):313-340. View Publication

3. Basse J, Ruha AM, Baumgartner K, Mullins ME, Green S, Wax P, Brent J, Campleman S, Schwarz E; On behalf of the ToxIC Snakebite Study Group . Clinical Presentations, Treatments, and Outcomes of Non-native Snake Envenomations in the United States Reported in the North American Snakebite Registry. J Med Toxicol. 2023;19(1):16-25. View Publication

4. Brandehoff N, Dalton A, Daugherty C, Dart RC, Monte AA; On behalf of the ToxIC Snakebite Study Group. Total CroFab and Anavip Antivenom Vial Administration in US Rattlesnake Envenomations: 2019-2021. J Med Toxicol. 2023;19(3):248-254. View Publication

5. Cohen N, Matthew M, Brent J, Wax P, Davis A, Obilom C, Burns MM, Canning J, Baumgartner K, Koons AL, Wiegand TJ, Judge B, Hoyte C, Chenoweth JA, Froberg B, Farrar H, Carey JL, Hendrickson RG, Hodgman M, Caravati EM, Christian MR, Wolk BJ, Seifert SA, Bentur Y, Levine M, Farrugia LA, Vearrier D, Minns AB, Kennedy JM, Kirschner RI, Aldy K, Schuh S, Campleman S, Li S, Myran DT, Feng L, Freedman SB, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Severe outcomes following pediatric cannabis intoxication: a prospective cohort study of an international toxicology surveillance registry. Clin Toxicol (Phila). 2023;61(8):591-598. View Publication

6. Devgun JM, Zhang R, Brent J, Wax P, Burkhart K, Meyn A, Campleman S, Abston S, Aldy K; On behalf of the ToxIC FACT Study Group. Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project. JAMA Netw Open. 2023;6(2):e2255815. View Publication

7. Glidden E, Suen K, Mustaquim D, Vivolo‑Kantor A, Brent J, Wax P, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). Characterization of Nonfatal Opioid, Cocaine, Methamphetamine, and Polydrug Exposure and Clinical Presentations Reported to the Toxicology Investigators Consortium Core Registry, January 2010-December 2021. J Med Toxicol. 2023;19(2):180-189. View Publication

8. Greene S, Gilbert M, Wolk B, Campleman S, Michelle-Ruha M; On behalf of the ToxIC Snakebite Study Group. Geographic variation in the clinical features of Mohave rattlesnake (Crotalus scutulatus) envenomations reported to the North American Snakebite Registry. Toxicon X. 2023;21:100171. View Publication

9. Levine M, Brent J, Wiegand T, Maguire B, Cohen N, Vaerrier D, Beuhler M, Leikin J, Ganetsky M, Stellpflug S, Ruha AM, Carey J, Geib AJ, Cao D, Kleinschmidt K, Vohra R, Riley B, Moore P, Schwarz E, Neavyn M, Rusyniak D, Greene S, Nogar J, Manini A, Wermuth M, Pizon A, Hendrickson R, Griswold M, Aldy K, Wax P, Spyres M, Campleman S, Macdonald E, Finkelstein Y; On behalf of the Toxicology Investigators Consoritum. Lipid emulsion therapy during management of the critically-ill poisoned patient: a prospective cohort study. Clin Toxicol (Phila). 2023;61(8):584-590. View Publication

10. Love J, Levine M, Aldy K, Brent J, Krotulski AJ, Logan BK, Vargas-Torres C, Walton SE, Amaducci A, Calello D, Hendrickson R, Hughes A, Kurt A, Judge B, Pizon A, Schwarz E, Shulman J, Wiegand T, Wax P, Manini AF; On behalf of the ToxIC Fentalog Study Group. Opioid overdoses involving xylazine in emergency department patients: a multicenter study. Clin Toxicol (Phila). 2023;61(3):173-180. View Publication

11. Simon M, Heard K; On behalf of the Toxicology Investigators Consortium (ToxIC).. Are antimuscarinic effects common in hydroxyzine overdose? A cohort analysis of antimuscarinic effects in hydroxyzine and diphenhydramine-poisoned patients. Clin Toxicol (Phila). 2023;61(5):379-386. View Publication

12. Simon M, Buchanan J, Schimmel J, Brent J, Burkhart K, Wax P, Taylor N, Aldy, K; On behalf of the ToxIC FACT Study Group. Adverse Events in Pregnant Patients Treated with Coronavirus Disease 2019 Therapeutics. J Med Toxicol. 2023;19(4)381-388. View Publication

13. Simpson M, Watson J, Whitledge J, Monuteaux M, Burns M; On behalf of the Toxicology Investigators Consortium (ToxIC). Intensive Care Interventions Among Children With Toxicologic Exposures to Cardiovascular Medications. Pediatr Crit Care Med. 2023;24(11):893-900. View Publication

14. Spyres M, Maker G, Aldy K, Meadors K, Christian M, Ruha M; On behalf of the ToxIC Snakebite Study Group. Compartment Syndrome after Crotalid Envenomation in the United States: A Review of the North American Snakebite Registry from 2013 to 2021. Wilderness Environ Med. 2023;34(3):322-327. View Publication

2022

1. Baumgartner K, Doering M, Mullins ME; On behalf of the Toxicology Investigators Consortium (ToxIC). Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database. Clin Toxicol (Phila). 2022;60(12):1356-1375. View Publication

2. Calello D, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, Brent J, Wax P, Walton S, Manini AF; On behalf of the ToxIC Fentalog Study Group. Identification of a Novel Opioid, N-piperidinyl etonitazene, in patients with suspected opioid overdose. Clin Toxicol (Phila). 2022:60(9):1067-1069. View Publication

3. Cohen N, Mathew M, Davis A, Brent J, Wax P, Schuh S, Freedman SB, Froberg B, Schwarz E, Canning J, Tortora L, Hoyte C, Koons AL, Burns MM, McFalls J, Wiegand TJ, Hendrickson RG, Judge B, Quang LS, Hodgman M, Chenoweth JA, Algren DA, Carey J, Caravati EM, Akpunonu P, Geib AJ, Seifert SA, Kazzi Z, Othong R, Greene SC, Holstege C, Tweet MS, Vearrier D, Pizon AF, Campleman SL, Li S, Aldy K, Finkelstein; On behalf of ToxIC Pediatric Opioid Exposure Study Group. Predictors of severe outcome following opioid intoxication in children. Clin Toxicol (Phila). 2022;60(6):702-707. View Publication

4. Farah R, Kazzi Z, Brent J, Burkhart K, Wax P, Aldy K;  On behalf of the ToxIC FACT Study Group. Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project. Clin Toxicol (Phila). 2022;60(8):942-946. View Publication

5. Filip AB, Berg SE, Mullins ME, Schwarz ES; On behalf of the Toxicology Investigators Consortium (ToxIC). Fomepizole as an adjunctive therapy for acetaminophen poisoning: cases reported to the toxicology investigators consortium (ToxIC) database 2015-2020. Clin Toxicol (Phila). 2022;60(9):1006-1011. View Publication

6. Griswold MK, Chai PR, Brent J, Weiss S, Askman N, Wax PM, Farrugia LA; On behalf of the Toxicology Investigators Consortium (ToxIC). Hydroxychloroquine and Chloroquine Toxicity as Reported by Medical Toxicologists to the Toxicology Investigators Consortium (ToxIC) Registry. J Med Toxicol. 2022;18(3):256-259. View Publication

7. Love J, Karshenas D, Spyres M, Farrugia, LA, Kang AM, Nguyen H, Campleman S, Li S, Wax P, Brent J, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium Case Registry — the 2021 Annual Report. J Med Toxicol. 2022;18(4):267-296. View Publication

8. Spyres MB, Padilla GK, Gerkin RD, Hoyte CO, Wold BJ, Ruha AM; On behalf of the ToxIC Snakebite Study Group. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab’)₂ (equine) antivenom and crotalidae immune polyvalent Fab (ovine) antivenom reported to the North American Snakebite Sub-registry. Clin Toxicol (Phila). 2022;60(7):838-842. View Publication

2021

1. Aldy K, Mustaquim D, Campleman S, Meyn A, Abston S, Krotulski A, Logan B, Gladden MR, Hughes A, Amaducci A, Shulman J, Schwarz E, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Notes from the Field: Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose — Four States, October 6, 2020–March 9, 2021. Morbidity and Mortality Weekly Report. 2021;70(34):1177–1179. View Publication

2. Desai NM, Mistry RD, Brou L, Boehnke ME, Lee JS, Wang GS; On behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric exposures reported to the Toxicology Investigators Consortium, 2010-2015. Pediatr Emer Care. 2021;37(12):e1039-e1043. View Publication

3. Gilley M, Brent J, Calello DP, Wax P, Finkelstein Y; On behalf of Toxicology Investigators Consortium (ToxIC). Synthetic Cannabinoid Exposure in Adolescents Presenting for Emergency Care. Pediatr Emer Care. 2021;37(1):e13-e16. View Publication

4. Greene S, Ruha AM, Campleman S, Brent J, Wax P; On behalf of the ToxIC Snakebite Study Group. Epidemiology, clinical features, and management of the Texas Coral Snake (Micrurus tener) envenomations reported to the North American Snakebite Registry.  J Med Toxicol. 2021;17(1):51-56. View Publication

5. Hughes AR, Lin A, Hendrickson RG; On behalf of the Toxicology Investigators Consortium (ToxIC). Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicity. Clin Toxicol (Phila). 2021;59(10):918-925. View Publication

6. Rianprakaisang TN, Prather CT, Lin AL, Murray BP, Hendrickson RG; On behalf of Toxicology Investigator’s Consortium (ToxIC). Factors associated with seizure development after bupropion overdose: A review of the Toxicology Investigators Consortium. Clin Toxicol (Phila). 2021;59(12):1234-1238. View Publication

7. Spyres MB, Aldy K, Farrugia LA, Kang AM, Love JS, Campleman S, Li S, Amaducci A, Schwarz E, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium 2020 Annual Report. J Med Toxicol. 2021;17(4):333-362. View Publication

8. Surmaitis RM, Greenberg MR, Ebeling-Koning NE, Grenz PM, McWhirter CR, Careyva BA, Sabino JN, Cook MD, Cannon RD, Koons AL, Katz KD, Kincaid H, Laubach LT, Beauchamp GA; On behalf of the Toxicology Investigators’ Consortium (ToxIC). Characteristics of transgender patient cases managed by a toxicologist: An analysis of the Toxicology Investigator’s Consortium (ToxIC) Registry: January 2017 – June 2019. J Med Toxicol. 2021;17(1):16-26. View Publication

9. Tebo C, Mazer-Amirshahi M, Wax P, Campleman S, Boyer E, Brent J, Sheth A, Daniuaityte R, Carlson R; On behalf of the IN3 Study Group. Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation. J Psychoactive Drugs. 2021;53(3):207-214. View Publication

10. Varney SM, Wiegand TJ, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Descriptive Analysis of Inpatient and Outpatient Cohorts Seeking Treatment After Prescription Opioid Misuse and Medical Toxicology Evaluation. J Med Toxicol. 2021; 17:378–385. View Publication

11. Weiss ST, Campleman S, Wax P , McGill W, Brent J; On behalf of The Toxicology Investigators Consortium (ToxIC). Failure of chelator-provoked urine testing results to predict heavy metal toxicity in a prospective cohort of patients referred for medical toxicology evaluation. Clin Toxicol (Phila).2021;60(2):191-196. View Publication

2020

1. Baumgartner K, Doering M, Schwarz E; On behalf of the Toxicology Investigators Consortium (ToxIC). Vilazodone poisoning: a systematic review. Clin Toxicol (Phila). 2020;58(5):360-367. View Publication

2. Beauchamp GA, Carey JL, Cook MD, Cannon RD, Katz KD, Yoon J, Kincaid H, Ely BJ, Pollack E, Mazzaccaro RJ, Greenberg MR; On behalf of Toxicology Investigator’s Consortium (ToxIC). Sex differences in pediatric poisonings by age group: A Toxicology Investigators Consortium (ToxIC) Analysis (2010-2016). J Med Toxicol. 2020;16(4):423-443. View Publication

3. Beauchamp GA, Carey JL, Hurwitz MB, Tully BN, Cook MD, Cannon RD, Katz KD, Koons AL, Greenberg MR; On behalf of Toxicology Investigator’s Consortium (ToxIC). Sex differences in substance use and misuse: A Toxicology Investigators Consortium (ToxIC) Registry Analysis. Subst Abuse Rehabil. 2020;11:23-31. View Publication

4. Beauchamp GA, Fishbein J, Makar GA, Pechulis RM, Cook MD, Cannon RD, Katz KD, Kincaid H, Carey JL, Greenberg M; On behalf of Toxicology Investigators Consortium (ToxIC). Sex differences in patients with suicidal intent that are managed by toxicologists. Am J Emerg Med. 2020;38(2):333-338. View Publication

5. Campleman SL, Brent J, Pizon AF, Shulman J, Wax p, Manini AF; On behalf of the Toxicology Investigator’s Consortium (ToxIC). Drug-specific risk of severe QT prolongation following acute drug overdose. Clin Toxicol (Phila). 2020;58(12):1326-1334. View Publication

6. Carreiro S, Miller S, Wang B, Wax P, Campleman S, Manini AF; On behalf of the ACMT Toxicology Investigators Consortium (ToxIC). Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clin Toxicol (Phila). 2020;58(3):183-189.  View Publication

7. Domanski K, Kleinschmidt KC, Greene S, Ruha AM, Berbata V, Onisko N, Campleman S, Brent J, Wax P; On behalf of the ToxIC North American Snakebite Study Group. Cottonmouth snake bites reported to the ToxIC North American snakebite registry 2013-2017. Clin Toxicol (Phila). 2020;58(3):178-182. View Publication

8. Levine M, Ruha A, Wolk B, Caravati M, Brent J, Campleman S, Wax P; On behalf of the ToxIC North American Snakebite Study Group. When it comes to snakebites, kids are little adults: A comparison of adults and children with rattlesnake bites. J Med Toxicol. 2020;16(4):444-451. View Publication

9. Mehrpour O, Hoyte C, Amirabadizadeh A, Brent J; On behalf of the Toxicology Investigator’s Consortium (ToxIC). Clinical characteristics and time trends of hospitalized methadone exposures in the United States based on the Toxicology Investigator’s Consortium (ToxIC) Case Registry: 2010-2017. BMC Pharmacol Toxicol. 2020;21(1):53. View Publication

10. Murray B, Carpenter J, Dunkley C, Moran TP, Kierman EA, Rianprakaisang T, Alsukaiti WS, Calello DP, Kazzi Z; On behalf of the Toxicology Investigators Consortium (ToxIC). Single-agent bupropion exposures: Clinical characteristics and an atypical cause of serotonin toxicity. J Med Toxicol. 2020;16(1):12-16. View Publication

11. Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, Li S, Beauchamp GA, Wiegand T, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium Case Registry – The 2019 Annual Report. J Med Toxicol. 2020;16(4):361-387. View Publication

2019

1. Anderson SAR, Oprescu AM, Calello DP, Monte A, Dayan PS, Hurd YL, Manini AF; On behalf of the Toxicology Investigators Consortium (ToxIC). Neuropsychiatric Sequelae in Adolescents with Acute Synthetic Cannabinoid Toxicity. Pediatrics. 2019;144(2):1-12. View Publication

2. Beauchamp GA, Amaducci A, Greenberg MR, Meyers M, Cook M, Cannon RD, Katz KD, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Adverse drug events and reactions managed by medical toxicologists: An analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010-2016. J Med Toxicol. 2019;15(4):262-270. View Publication

3. Friedman N, Shoshani-Levy M, Bren J, Wax P, Campleman SL, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Fatalities in poisoned patients managed by medical toxicologists. Clin Toxicol (Phila). 2019;58(7):688-691. View Publication

4. Gauthey M, Capua M, Brent J, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Poisoning with malicious or criminal intent: Characteristics and outcome of patients presenting for emergency care. Clin Toxicol (Phila). 2019;57(7):628-631. View Publication

5. Moss MJ, Hendrickson RG; On behalf of the Toxicology Investigators Consortium (ToxIC). Serotonin Toxicity: Associated Agents and Clinical Characteristics. J Clin Psychopharmacol. 2019;39:628-633. View Publication

6. Murray BP, Carpenter JE, Dunkley CA, Moran TP, Alfaifi M, Alsukaiti WS, Kazzi Z; On behalf of the Toxicology Investigators Consortium (ToxIC). Seizures in Tramadol Overdoses Reported in the ToxIC Registry: Predisposing Factors and the Role of Naloxone. Clin Toxicol (Phila). 2019;57(8):692-696. View Publication

7. Spyres MB, Farrugia LA, Kang AM, Calello DP, Campleman SL, Pizon A, Wiegand T, Kao L, Riley BD, Li S, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report. J Med Toxicol. 2019;15(4):228-254. View Publication

2018

1. Beauchamp GA, Carey JL, Adams T, Wier A, Colón MF, Cook M, Cannon R, Katz KD, Greenberg MR; On behalf of the Toxicology Investigators Consortium (ToxIC). Sex differences in poisonings among older adults: An analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010 to 2016. Clin Ther. 2018;40(8):1366-1374. View Publication

2. Farrugia LA, Rhyee SH, Campleman SL, Judge B, Kao L, Pizon A, Porter L, Riederer AM, Wiegand T, Calello D, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium Case Registry – The 2017 Annual Report. J Med Toxicol. 2018;14(4):182-211. View Publication

3. Kleinschmidt K, Ruha AM, Campleman S, Brent J, Wax P; On behalf of the ToxIC Snakebite Study Group. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry. Clin Toxicol (Phila). 2018;56(11):1115-1120. View Publication

4. Spyres MB, Ruha AM, Kleinschmidt K, Vohra R, Smith E, Padilla-Jones A; On behalf of the Toxicology Investigators Consortium (ToxIC). Epidemiology and clinical outcomes of snakebite in the elderly: A ToxIC database study. Clin Toxicol (Phila). 2018;56(2):108-112. View Publication

2017

1. Farrugia LA, Rhyee SH, Calello DP, Campleman SL, Riederer AM, Malashock HR, Pizon A, Wiegand T, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC).  The Toxicology Investigators  Consortium Case Registry – The 2016 Experience.  J Med Toxicol. 2017;13(3):203-226. View Publication

2. Finkelstein Y, Goel G, Hutson JR, Armstrong J, Baum CR, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Drug misuse in adolescents presenting to the emergency department. Pediatr Emerg Care. 2017;33(7):451-456. View Publication

3. Heise CW, Malashock H, Brooks DE; On behalf of the Toxicology Investigators Consortium (ToxIC). A review of vilazodone exposures with focus on serotonin syndrome effects. Clin Toxicol (Phila). 2017;55(9):1004-1007. View Publication

4. Ho JH, Leikin JB, Dargan PI, Archer JRH, Wood DM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Metal-on-Metal hip joint prostheses: A retrospective case series investigating the association of systemic toxicity with serum cobalt and chromium concentrations. J Med Toxicol. 2017;13(4):321-328.  View Publication

5. Monte AA, Calello DP, Gerona RR, Hamad E, Campleman SL, Brent J, Wax P, Carlson RG; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: A ToxIC Database Study. J Med Toxicol. 2017;13(2):146-152. View Publication

6. Rasimas JJ, Smolcic EE, Sinclair CM; On behalf of the Toxicology Investigators Consortium (ToxIC). Themes and trends in intentional self-poisoning: Perspectives from critical care toxicology. Psychiatry Res. 2017;255:304-313. View Publication

7. Ruha AM, Kleinschmidt KC, Greene S, Spyres MB, Brent J, Wax P, Padilla-Jones A, Campleman S; On behalf of the ToxIC Snakebite Study Group. The epidemiology, clinical course, and management of snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13(4):309-320. View Publication

2016

1. Beauchamp GA, Hendrickson, RG, Hatten BW; On behalf of the Toxicology Investigators Consortium (ToxIC). Endotracheal intubation for toxicologic exposures: A retrospective review of Toxicology Investigators Consortium (ToxIC) cases. J Emerg Med. 2016;51(4):382-388. View Publication

2. Farrugia LA, Rhyee SH, Campleman SL, Ruha AM, Weigand T, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The Toxicology Investigators Consortium Case Registry – The 2015 Experience. J Med Toxicol. 2016;12(3):224-247. View Publication

3. Judge BS, Ouellette LM, VandenBerg M, Riley BD, Wax PM; On behalf of the Toxicology Investigators Consortium (ToxIC). Utilization of observation units for the care of poisoned patients: Trends from the Toxicology Investigators Consortium Case Registry. J Med Toxicol. 2016;12:111-120. View Publication

4. Riederer, AM, Campleman Sl, Carlson RG, Boyer EW, Manini AF, Wax PM, Brent JA; On behalf of the Toxicology Investigators Consortium (ToxIC). Acute poisonings from synthetic cannabinoids—50 US Toxicology Investigators Consortium Registry Sites, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(27);692–695. View Publication

5. Spyres MB, Ruha AM, Seifert S, Onisko N, Padilla-Jones A, Smith EA; On behalf of the ToxIC Snakebite Study Group. Occupational snake bites: A prospective case series of patients reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2016;12(4):365-369. View Publication

6. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S; On behalf of the Toxicology Investigators Consortium (ToxIC). Extracorporeal Membrane Oxygenation (ECMO) for severe toxicological exposures: Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016;12(1):95-9. View Publication

2015

1. Finkelstein Y, Goel G, Hutson JR, Armstrong J, Baum CR, Wax P, Brent J. Drug misuse in adolescents presenting to the emergency department. Pediatr Emerg Care. 2015;33(7):451-456. View Publication

2. Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, Mckeown NJ, Rosenbaum CD, Young AC, Rusyniak DE. Acute Methylenedioxypyrovalerone Toxicity. J Med Toxicol. 2015;11(2):185-94. View Publication

3. Rhyee SH, Farrugia L, Campleman SL, Wax PM, Brent J. The Toxicology Investigators Consortium Case Registry—the 2014 Experience. J Med Toxicol. 2015;11(4):388-409. View Publication

4. Smith SW, Farmer BM. Toxicology in the service of patient and medication safety: A selected glance at past and present innovations. J Med Toxicol. 2015;11(2):245-252. View Publication

5. Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME. The use of Physostigmine by toxicologists in anticholinergic toxicity. J Med Toxicol. 2015;11(2):179-184. View Publication

6. Zelner I, Matlow J, Hutson JR, Wax P, Karen G, Brent J, Finkelstein Y. Acute poisoning during pregnancy: Observations from the Toxicology Investigators Consortium. J Med Toxicol. 2015;11(3):301-308. View Publication

2014

1. Rhyee S, Farrugia L, Wiegand T, Smith EA, Wax PM, Brent J. The Toxicology Investigators Consortium Case Registry—the 2013 Experience. J Med Toxicol. 2014;10(4):342-359. View Publication

2013

1. Finkelstein Y, Hutson JR, Freedman SB, Wax PM, Brent J. Drug-induced seizures in children and adolescents presenting for emergency care: Current and emerging trends.Clin Toxicol (Phila). 2013;51(8):761-766. View Publication

2. Wiegand TJ, Wax PM, Smith E, Hart K, Brent J. The Toxicology Investigators Consortium Case Registry—The 2012 Experience. J Med Toxicol. 2013;9(4):380-404. View Publication

2012

1. Finkelstein Y, Hutson JR, Wax PM, Brent J. Toxico-Surveillance of infant and toddler poisonings in the United States. J Med Toxicol. 2012;8(3):263-266. View Publication

2. Geib AJ, Liebelt E, Manini AF. Clinical experience with intravenous lipid emulsion for drug-induced cardiovascular collapse. J Med Toxicol. 2012;8(1):10-14. View Publication

3. Wiegand TJ, Wax PM, Schwartz T, Finkelstein Y, Gorodetsky R, Brent J. The Toxicology Investigators Consortium Case Registry—The 2011 Experience. J Med Toxicol. 2012;8(4):360-377. View Publication

 2011

1. Brent J, Wax PM, Schwartz T, Kleinschmidt KC, Engebretsen K, Beuhler M. The Toxicology Investigators Consortium Case Registry—The 2010 Experience. J Med Toxicol. 2011;7(4):266-276. View Publication

2. Wax PM, Kleinschmidt KC, Brent J. The Toxicology Investigators Consortium (ToxIC) Registry. J Med Toxicol. 2011;7(4):259-265. View Publication

2024

1. Amaducci A, Culbreth R, Wax P, Aldy K, Brent J, Campleman S, Li S, Krotulski AK, Love J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Is Chronic Pain Associated With Fentanyl or Fentanyl-Analog Overdoses in ED Patients? J Med Toxicol. 2024;20:91. View Abstract

2. Borst E, Chary M; On behalf of the Toxicology Investigators Consortium (ToxIC). Do abnormal electrocardiographic intervals predict death in poisoned patients older than 65 years? Clin Toxicol (Phila). 2024;62:43.  View Abstract

3. Campleman S, Culbreth R, Li S, Aldy K, Brent J, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Utility of a Multicenter Clinical Surveillance System to Describe the Variability of N-Acetyl Cysteine Treatment in Single Agent Acetaminophen Poisonings. J Med Toxicol. 2024;20:60-61. View Abstract

4. Carpenter J, Culbreth R, Wax P, Aldy K, Brent J, Campleman S, Li S, Shastry S, Berger J, Manini A; On behalf of the ToxIC Fentalog Study Group. Buprenorphine and Naloxone Prescribing After Opioid Overdose: A Report From Ten Academic Hospital Systems. J Med Toxicol. 2024;20:78-79. View Abstract

5. Chary M, Wax P, Culbreth R, Aldy K, Campleman S, Falise A, Hendrickson R, Krotulski A, Burkhart K, Jimoh O, Meyn A, Brent J; On behalf of the ToxIC DOTS Study Group. Characteristics of toxicological exposures among unhoused individuals compared to patients with secured housing. Clin Toxicol (Phila). 2024;62:25-26.  View Abstract

6. Chary M, Wax P, Culbreth R, Burkhart K, Campleman S, Dezman Z, Naples J, Aldy K, Abston S, Krotulski A, Brent J; On behalf of the ToxIC DOTS Study Group. The ratio of serum fentanyl to norfentanyl is associated with the level of care needed after nonfatal opioid overdose. Clin Toxicol (Phila). 2024;62:35-36.  View Abstract

7. Culbreth C, Aldy K, Krotulski A, Brent J, Campleman S, Li S, Abston S, Logan B, Wax P, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Schwarz E, Carpenter J, Buchanan J, Manini A; On behalf of the ToxIC Fentalog Study Group. Oxycodone overdose is associated with the intention to self-harm among emergency department patients. Clin Toxicol (Phila). 2024;62(1)98. View Abstract

8. Culbreth R, Wax P, Brent J, Aldy K, Dernbach M, Rasimas J, Hulsey J, Kennedy A, Parris K, Natafgi N; In collaboration with the Toxicology Investigators Consortium (ToxIC). Research Priorities for Intentional Overdoses: An Approach to Advance Medical Toxicology Research Through Patient Engagement. J Med Toxicol. 2024;20:89. View Abstract

9. DeCoy M, Culbreth R, Cao D, Brent J, Aldy K, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Comparative Analysis of Pediatric Drug Overdoses Requiring ICU: Before, During, and After the COVID-19 Pandemic. J Med Toxicol. 2024;20:45-46. View Abstract

10. DelBianco J, Galeano K, Stirparo J, Wheel K, Beauchamp G, Surmaitis R, Amaducci A; On behalf of the Toxicology Investigators Consortium (ToxIC). Trends in Alcohol Withdrawal Management: A Single-Site Analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry 2017-2022. J Med Toxicol. 2024;20:87. View Abstract

11. Delbianco J, Willing T, Galeano K, Beauchamp G, Amaducci A; On behalf of the Toxicology Investigators Consortium (ToxIC). Use of methylene blue to treat hypotension in poisoned patients in the Toxicology Investigators Consortium (ToxIC) Core Registry: 2016–2023. Clin Toxicol (Phila). 2024;62:28-29.  View Abstract

12. Dicker F, Ancona R, Baumgartner K; On behalf of the Toxicology Investigators Consortium (ToxIC). Treatment of Severe Alcohol Withdrawal, a Cross-Sectional Study of the Toxicology Investigators Consortium Database. J Med Toxicol. 2024;20:87. View Abstract

13. Han D, Bonney C, Hatten B; On behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric alpha-2 agonist exposures in the ToxIC Registry. Clin Toxicol (Phila). 2024;62(1)25. View Abstract

14. Hughes A, Culbreth R, Aldy K, Brent J, Wax P, Krotulski A, Li S, Campleman S, Logan B, Manini A; On behalf of the ToxIC Fentalog Study Group. Clinical Correlates of Confirmed Benzodiazepine and Opioid Co-Exposures Among Patients Presenting to the Emergency Department. J Med Toxicol. 2024;20:26-27. View Abstract

15. Hughes A, Culbreth R, Aldy K, Krotulski A, Brent J, Campleman S, Li S, Abston S, Logan B, Wax P, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Schwarz E, Carpenter J, Buchanan J, Manini A; On behalf of the ToxIC Fentalog Study Group. Additional morbidity of co- exposure to novel psychoactive benzodiazepines in Emergency Department patients with confirmed opioid overdose. Clin Toxicol (Phila). 2024;62(1)28. View Abstract

16. Jimoh O, Culbreth R, Aldy K, Brent J, Campleman S, Krotulski A, Wax P, Naples J, Dezman Z, Burkhart K; On behalf of the ToxIC DOTS Study Group. Clinical characteristics after naloxone administration in patients with confirmed methamphetamine and cocaine exposures in the Drug Overdose Toxico-Surveillance (DOTS) reporting program.  Clin Toxicol (Phila) .2024;62:37.  View Abstract

17. Jimoh O, Wax P, Aldy K, Brent J, Culbreth R, Campleman S, Krotulski AK, Meyn A, Abston S, Burkhart K; On behalf of the ToxIC DOTS Study Group. Preliminary Results From the Drug Overdose Toxico-Surveillance (DOTS) Reporting Program: Admission Status by Sociodemographic Characteristics. J Med Toxicol. 2024;20:81. View Abstract

18. Laub D, Amirshahi M, Stolbach A, Aldy K, Campleman S, Brent J, Culbreth R, Krotulski A, Burkhart K, Wax P; On behalf of the ToxIC DOTS Study Group. Synthetic cathinones among patients presenting to emergency departments with life-threatening or severe overdose. Clin Toxicol (Phila). 2024;62:58. View Abstract

19. Lebin J, Culbreth R, Wax P, Burkhart K, Dezman Z, Naples J, Aldy K, Campleman S, Brent J, Falise A, Levine M, Chary M, Krotulski A, Perrone J; On behalf of the ToxIC DOTS Study Group. Fentanyl and norfentanyl blood concentrations among severe/life- threatening opioid overdose patients stratified by self-reported opioid use patterns. Clin Toxicol (Phila). 2024;62:22-23. View Abstract

20. McDonald C, Farah R, Nixon S, Charlton N; On behalf of the Toxicology Investigators Consortium (ToxIC). Comparison of Serotonin and Norepinephrine Reuptake Inhibitor Toxicity in Overdose Using Toxicology Investigators Consortium Database. J Med Toxicol. 2024;20:49-50. View Abstract

21. Perrone J, Culbreth R, Aldy K, Brent J, Krotulski A, Naples J, Dezman Z, Burkhart K, Wax P; On behalf of the ToxIC DOTS Study Group. Quantitative xylazine and fentanyl concentrations following nonfatal opioid overdose from the Toxicology Investigators Consortium Drug Overdose Toxico-Surveillance (DOTS) reporting program multicenter study. Clin Toxicol (Phila). 2024;62:12. View Abstract

22. Schwarz ES, Culbreth R, Buchanan J, Aldy K, Brent J, Wax P, Levine M, Suarez F, Kumar A, Manini A; On behalf of the ToxIC Fentalog Study Group. Precipitated Withdrawal in Emergency Department Patients Following a Presumed Opioid Overdose. J Med Toxicol. 2024;20:36-37. View Abstract

23. Shanahan E, Mitchell C, Font A, Khoury M, Krueger J; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics and Outcomes of Enteral Caustic Exposures Described in the Toxicology Investigators Consortium (ToxIC) Core Registry. J Med Toxicol. 2024;20:72. View Abstract

24. Simpson M, Campleman S, Brent J, Wax P, Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC). Initial Serum Lactate Predicts Adverse Cardiovascular Events in Emergency Department Patients with Bupropion Overdose. J Med Toxicol. 2024;20:20-21. View Abstract

25. Simpson M, Tang K, Manini M, Burns M; On behalf of the Toxicology Investigators Consortium (ToxIC). Toxin-induced QTc prolongation: exposure and patient characteristics associated with ventricular dysrhythmias. Clin Toxicol (Phila). 2024;62:20. View Abstract

26. Spungen H, Culbreth R, Aldy K, Brent J, Wax P, Krotulski AK, Li S, Campleman S, Logan B, Abston S; On behalf of the ToxIC Fentalog Study Group. Geographic Variability of Novel Potent Opioids and Associated Emerging Substances Detected in Emergency Department Patients. J Med Toxicol. 2024;20:78. View Abstract

27. Spyres M, Glaser T, Culbreth R, Libelt E, Greene S, Ruha A; On behalf of the ToxIC Snakebite Study Group. Analysis of Acute Hypersensitivity Reactions by Antivenom Type by Geographic Location in the North American Snake Bite Registry. J Med Toxicol. 2024;20:34-35. View Abstract

28. Suarez F, Massengill D, Buchanan J, Kumar A, Culbreth R, Aldy K, Brent J, Wax P, Campleman S, Manini AF; On behalf of the ToxIC Fentalog Study Group. Opioid Drug Concealment and Treatment Requirements in ED Patients With Confirmed Opioid Overdose. J Med Toxicol. 2024;20:77-78. View Abstract

29. Sutphin A, Falise A, Aldy K, Culbreth, Brent J, Kumar A, Buchanan J, Campleman S, Krotulski A, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Mechanical ventilation requirements in emergency departments patients with confirmed opioid overdose. Clin Toxicol(Phila). 2024;62:21. View Abstract

30. Sutphin A, Falise A, Aldy K, Campleman S, Culbreth R, Burkhart K, Brent J, Krotulski A, Abston S, Meyn A; On behalf of the ToxIC DOTS Study Group. Bromazolam blood concentrations in patients presenting to the emergency department after an opioid or stimulant overdose.  Clin Toxicol (Phila). 2024;62:23.  View Abstract

31. Wax P, Aldy K, Burkhart K, Diak I, Lopez A, Naples J, Culbreth RE, Krotulski AK, Campleman S, Brent J; On behalf of the ToxIC DOTS Study Group. Incorporating Quantitative Drug Analysis Into Non-Fatal Drug Overdose Surveillance: The Toxicology Investigators Consortium Drug Overdose Toxico-Surveillance (DOTS) Reporting Program. J Med Toxicol. 2024;20:85. View Abstract

32. Wax P, Culbreth R, Brent J, Aldy K, Costantini M, Li S, Murchison P, Meyn A, Campleman S; On behalf of the Toxicology Investigators Consortium (ToxIC). Fatalities From Drug Overdoses and Predictors for Withdrawal of Life Support and Brain Death Determination, 2017-2023. J Med Toxicol. 2024;20:30 View Abstract

33. Wax P, Culbreth R, Murchison P, Campleman S, Falise A, Amaducci A, Costantini M, Aldy K, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics of toxicological exposures among unhoused individuals compared to patients with secured housing. Clin Toxicol (Phila). 2024;62:24-25. View Abstract

34. Weiss S, Culbreth R, Falise A, Aldy K, Smith K, Wax P, Campleman S, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Increasing incidence of kratom- associated serious adverse effects in medical toxicology patients. Clin Toxicol (Phila). 2024;62:50. View Abstract

35. Whitledge J, Burns M, Farmer B, Fox E, Mazer-Amirshahi M; On behalf of the Toxicology Investigators Consortium (ToxIC). Drug Shortage Outcomes and Solutions Reported to the ToxIC Registry Over a Six-Month Period. J Med Toxicol. 2024;20:70-71. View Abstract

36. Williams L, Spyres M, Greene S, Wolk B, Campleman S, Aldy K, Ruha M; On behalf of the ToxIC Snakebite Study Group. Sidewinder (Crotalus cerastes) Bites Reported to the ToxIC North American Snakebite Registry (NASBR). J Med Toxicol. 2022;20:70-71. View Abstract

2023

1. Ahsan S, Carpenter JE, Kiernan EA; On behalf of the Toxicology Investigators Consortium (ToxIC). Methotrexate Toxicity: A Report From The ToxIC Registry. J Med Toxicol. 2023;19(2):81. View Abstract

2. Aldy K, Wax P, Culbreth R, Krotulski A, Brent J, Campleman S, Logan B, Meyn A, Manini A; On behalf of the ToxIC Fentalog Study Group. The Prevalence of Novel Psychoactive Substances in Opioid Overdose Patients. J Med Toxicol. 2023;19(2):117-118. View Abstract

3. Aldy K, Culbreth RE, Hantsch C, Mikhailov T, Brundage N, Wax P, Brent J; In collaboration with the Toxicology Investigators Consortium (ToxIC).  Medical Toxicology Consultations for Poisoned Children Managed in Pediatric Intensive Care Units.  J Med Toxicol. 2023;19(2):65. View Abstract

4. Aldy K, Culbreth R, Love J, Wax P, Campleman S, Brent J, Krotulski A, Levine M, Buchanan J, Manini A; On behalf of the ToxIC Fentalog Study Group. Clinical and demographic correlates of confirmed xylazine and levamisole exposure among ED patients with acute fentanyl overdose. Clin Toxicol (Phila). 2023;61:4-5. View Abstract

5. Campleman S, Li S, Aldy K, Culbreth R, Krotulski A, Schwarz E, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Prevalence of Laboratory Confirmed Hallucinogens within an Emergency Department-Derived Opioid Overdose Cohort. J Med Toxicol.  2023;19(2):117. View Abstract

6. Cohen N, Mathew M, Brent J, Wax P, Davis A, Obilom C, Burns MM, Canning J, Baumgartner K, Finkelstein Y; On behalf of ToxIC Pediatric Cannabis Study Group. Severe Outcomes Following Pediatric Cannabis Intoxications: A Prospective Cohort Study of an International Toxicology Surveillance Registry. J Med Toxicol. 2023;19(2):126. View Abstract

7. Culbreth R, Aldy K, Wax P, Krotulski A, Brent J, Campleman, Logan B, Li S, Manini A; On behalf of the ToxIC Fentalog Study Group. Geographical Differences in Opioid, Stimulant, and Benzodiazepine Use Among Suspected Opioid Overdoses Presenting to the Emergency Department. J Med Toxicol.  2023;19(2):119-120. View Abstract

8. Culbreth R, Aldy K, Wax P, Campleman S, Brent J, Krotulski A, Li S, Abston S, Logan B, Manini A; On behalf of the ToxIC Fentalog Study Group. Confirmed drug exposures in ED patients presenting after opioid overdose with selfharm intent. Clin Toxicol (Phila). 2023;61:89. View Abstract

9. Culbreth R, Brent J, Wax P, Aldy K, Costantini M, Li S, Murchison P, Meyn A, Campleman S; On behalf of the Toxicology Investigators Consortium (ToxIC). History of Overdose and Psychiatric Comorbidities among Medical Toxicology Consultations in the ToxIC Core Registry, 2021-2022. Clin Toxicol (Phila). 2023;61:49. View Abstract

10. Culbreth R, Wax P, Aldy K, Hantsch C, Mikhailov T, Brundage N, Brent J; In collaboration with the Toxicology Investigators Consortium (ToxIC). Pediatric Risk of Mortality-III (PRISM III) and Pediatric Index of Mortality (PIM3) Scores among Pediatric Poisonings.  J Med Toxicol. 2023;19(2):64. View Abstract

11. Dion C, Gerkin R, Hoyte C, Wolk B, Campleman S, Ruha AM; On behalf of the ToxIC Snakebite Study Group. Interspecies Differences in Rattlesnake Envenomations in the Western United States Reported to the North American Snakebite Registry. J Med Toxicol. 2023;19(2):99. View Abstract

12. Glidden E, Mustaquim D; On behalf of the Toxicology Investigators Consortium (ToxIC). Changes in Route of Administration Among People Who Use Fentanyl, ToxIC Core Registry, 2014-2021. J Med Toxicol. 2023;19(2):116. View Abstract

13. Glidden E, Mustaquim D, Culbreth R; On behalf of the Toxicology Investigators Consortium (ToxIC). Descriptive Characteristics Of Persons Who Use Fentanyl Within The ToxIC Core Registry, 2014–2022. Clin Toxicol (Phila). 2023;61:45. View Abstract

14. Goodrich W, Wax P, Aldy K, Culbreth R, Krotulski A, Brent J, Campleman S, Logan B, Amaducci A, Manini A; On behalf of the ToxIC Fentalog Study Group. Levamisole: A Classic Adulterant with a Novel Association. J Med Toxicol. 2023;19(2):107-108. View Abstract

15. Hendrickson R, Chettat S; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics of poisoning- associated rhabdomyolysis in various age groups. Clin Toxicol (Phila). 2023;61:59-60. View Abstract

16. Hoang R, Culbreth R, Aldy K, Campleman S, Wax P, Meyn A, Li S, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Trends in Pregnancy and Overdose Reported to the Toxicology Investigators Consortium (ToxIC) Core Registry 2014-2021. J Med Toxicol. 2023;19(2):89. View Abstract

17. Hornton SL, Wong E, Rianprakaisang TN; On behalf of the Toxicology Investigators Consortium (ToxIC). Adult Loxoscelism: A Review of Brown Recluse Bites in the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2023;19(2):154. View Abstract

18. Hughes A, Culbreth R, Aldy K, Li S, Campleman S, Logan B, Brent J, Krotulski A, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Benzodiazepine co-exposure among patients treated in the emergency department with suspected opioid overdose. Clin Toxicol (Phila). 2023;61:42. View Abstract

19. Jurao AR, Spyres MB, Wolk MD, Campleman S, Ruha AM; On behalf of the ToxIC Snakebite Study Group. Characteristics of Crotalid Venom-Induced Neurotoxicity in the North American Snakebite Registry (NASBR). J Med Toxicol. 2023;19(2):146. View Abstract

20. Levine M, Culbreth R, Buchanan J, Schwarz E, Aldy K, Campleman S, Krotulski A, Brent J, Wax P; On behalf of the ToxIC Fentalog Study Group. Prevalence of HIV among patients presenting with acute opioid toxicity. Clin Toxicol (Phila). 2023;61:28-29. View Abstract

21. Levine M, Culbreth R, Buchanan J, Schwarz E, Aldy K, Campleman S, Krotulksi A, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Use of naloxone upon discharge. Clin Toxicol (Phila). 2023;61:29. View Abstract

22. Levine M, Culbreth R, Buchanan J, Schwarz E, Aldy K, Campleman S, Krotulksi A, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Xylazine trends over time. Clin Toxicol (Phila). 2023;61:28. View Abstract

23. Levine M, Pizon AF, Boyle K, Schwarz E, Sharma K, Carey J, Amirshahi M, Hendrickson R, Olives T, Heard K, Brent J, Lavonas E, Wax P, Devgun J, Kazzi Z, Chary M, Schimmel J, Spyres M, Aldy K, Wiegand T, Marlin M, Shiekh S, Rianprakaisang T; On behalf of the ToxIC FACT Study Group. Adverse Drug Events Associated With Remdesivir Among Hispanic Populations. J Med Toxicol. 2023;19(2):142-143. View Abstract

24. Love J, Culbreth R, Aldy K, Wax P, Campleman S, Brent J, Krotulski A, Li S, Logan B, Manini A; On behalf of the ToxIC Fentalog Study Group. Predictors of xylazine positivity in emergency department patients with opioid overdose. Clin Toxicol (Phila). 2023;61:4. View Abstract

25. Love J, Culbreth R, Aldy K, Kaplan S, Wax P, Campleman S, Brent J, Krotulski A, Li S, Logan B, Manini A; On behalf of the ToxIC Fentalog Study Group. Differences in naloxone dosing by gender in emergency department opioid overdose: results of a multicenter study. Clin Toxicol (Phila). 2023;61:44-45. View Abstract

26. Matlock M, Liss DB; On behalf of the Toxicology Investigators Consortium (ToxIC). Clinical Features of Benzonatate Poisoning Cases Reported in the Toxicology Investigator’s Consortium Registry. J Med Toxicol. 2023;19(2):100. View Abstract

27. Renny MH, Aldy K, Brent J, Wax P, Krotulski A, Campleman S, Logan B, Calello D, Culbreth R, Manini A; On behalf of the ToxIC Fentalog Study Group. Young Adults With Acute Opioid Overdose: What Substances Are Actually Involved? J Med Toxicol. 2023;19(2):128-129. View Abstract

28. Renny M, Aldy K, Brent J, Wax P, Krotulski A, Campleman S, Calello D, Culbreth R, Manini A; On behalf of the ToxIC Fentalog Study Group. Young Adults With Acute Opioid Overdose: What Substances Are Actually Involved? Pediatric Academic Societies. 2023;E-PASS 5555.543 

29. Rianprakaisang TN, Wong E, Thornton SL; On behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric Loxoscelism: A Review of Brown Recluse Bites in the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2023;19(2):153-154. View Abstract

30. Rianprakaisang TN, Wong E, Thornton SL; On behalf of the Toxicology Investigators Consortium (ToxIC). Latrodectus Envenomations in Pediatric Patients: A Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2023;19(2):153. View Abstract

31.Rianprakaisang, Wong E; On behalf of the Toxicology Investigators Consortium (ToxIC). Comparing beta blocker ingestions: a review of the Toxicology Investigators Consortium database. Clin Toxicol (Phila). 2023;61:87-88. View Abstract

32. Ruha AM, Spyres MB, Culbreth R, Wolk B, Hoyte C, Campleman S; On behalf of the ToxIC Snakebite Study Group. Systemic Toxicity after Rattlesnake Envenomation in Patients Using Angiotensin Converting Enzyme Inhibitors in the North American Snakebite Registry. J Med Toxicol. 2023;19(2):130-131. View Abstract

33. Ryan K, Spungen H, Tershera M, Greene S, Warpinski G, Aldy K, Ruha AM; On behalf of the ToxIC Snakebite Study Group. The Circumstances Surrounding Snakebite in the United States: A Survey of Surreptitious Serpent-Person Skirmishes. Clin Toxicol (Phila). 2023;61:113. View Abstract

34. Schimmel J, Epperson LC, Aldy K, Wax P, Brent J, Buchanan J, Levine M; On behalf of the ToxIC FACT Study Group. Remdesivir Discontinuation Based on Thresholds of Transaminase Elevation in an Observational Registry. J Med Toxicol. 2023;19(2):139. View Abstract

35. Shanahan E, Mitchell C, Krueger J, Walsh S; On behalf of the Toxicology Investigators Consortium (ToxIC). Predictors of Inpatient Mortality in Colchicine Toxicity: An Analysis of the Toxicology Investigators Consortium Registry. J Med Toxicol. 2023;19(2):82. View Abstract

36. Shastry S, Aldy K, Brent J, Wax P, Krotulski A, Campleman S, Li S, Meyn A, Abston S, Logan B, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Hughes A, Culbreth A, Schwarz E, Manini A; On behalf of the ToxIC Fentalog Study Group. Disparities in Access to Naloxone and Buprenorphine in Emergency Department Patients With Opioid Overdose. Acad Emerg Med. 2023;30(S1):385. View Abstract

37. Shastry S, Aldy K, Brent J, Wax P, Krotulski A, Logan B, Campleman S, Culbreth R, Manini A; On behalf of the ToxIC Fentalog Study Group. Heroin or Fentanyl: Prevalence of Confirmed Fentanyl in ED Patients with Suspected Heroin Overdose. J Med Toxicol. 2023;19(2):18-19. View Abstract

38. Simon M, Pepin L, Buchanan J, Brent J, Wax P, Aldy K; On behalf of the ToxIC FACT Study Group. Adverse Events in Pediatric Patients Treated with COVID-19 Therapeutics Reported to the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project. J Med Toxicol. 2023;19(2):143-144. View Abstract

39. Simon M, Kaplan S, Muschler K, Hoyte C, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). The Role of the QRS Interval Prolongation in Prognosticating Severe Toxicity in Overdose. Clin Toxicol (Phila). 2023;61:88-89. View Abstract

40. Simpson M, Campleman S, Brent J, Wax P, Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC). Predicting adverse cardiovascular events in bupropion overdose. Clin Toxicol (Phila). 2023;61:106. View Abstract

41. Simpson M, Monuteaux MC, Burns MM; On behalf of the Toxicology Investigators Consortium (ToxIC). QRS Widening As a Risk Factor for Adverse Cardiovascular Events in Bupropion Exposures: A ToxIC Registry Study.  J Med Toxicol. 2023;19(2):98-99. View Abstract

42. Tang KB, Simpson MD, Burns MM; On behalf of the Toxicology Investigators Consortium (ToxIC). Toxicological Exposures in Patients With QRS Widening as Described in the ToxIC Database. J Med Toxicol. 2023;19(2):140. View Abstract

43. Troger A, Toce MS; On behalf of the Toxicology Investigators Consortium (ToxIC). Frequency of Critical Care Interventions by Mechanism of Action in Pediatric Anti-Epileptic Drug Overdose.  J Med Toxicol. 2023;19(2):66. View Abstract

44. Wax P, Culbreth R, Brent J, Aldy K, Krotulski A, Campleman S, Logan B, Abston S, Manini A; On behalf of the ToxIC Fentalog Study Group. Yearly Trends and Regional Patterns of Novel Psychoactive Substances in Opioid Overdose Patients. J Med Toxicol. 2023;19(2):128. View Abstract

45. Weiss S, Li X, Aldy K, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Trends in the Intent and Drug Classes Used in Opioid Overdose Cases Treated by Medical Toxicologists. Clin Toxicol (Phila). 2023;61:27-28. View Abstract

46. Winkels J, Mullins M, Liss D, Kaplan S; On behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric intravenous acetaminophen overdoses reported in the Toxicology Investigators Consortium (ToxIC) Registry. Clin Toxicol (Phila). 2023;61:65-66. View Abstract

47. Winkels J, Liss D; On behalf of the Toxicology Investigators Consortium (ToxIC). Treatment of Phenytoin Poisoning by Medical Toxicologists. J Med Toxicol. 2023;19(2):69. View Abstract

48. Wong E, Thornton SL, Rianprakaisang TN; On behalf of the Toxicology Investigators Consortium (ToxIC). Latrodectus Envenomations in Adult Patients: A Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2023;19(2):152-153. View Abstract

2022

1. Aldy K, Krotulski A, Campleman S, Meyn A, Abston S, Logan B, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Para-Fluorofentanyl Detected in Patients with Suspected Opioid Overdose. J Med Toxicol. 2022;18:107-108. View Abstract

2. Amaducci A, Aldy K, Campleman S, Meyn A, Abston S, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Brorphine, Isotonitazene and Metonitazene Emerge as New Age Opioids. J Med Toxicol. 2022;18:87-88. View Abstract

3. Atti S, Ryan E, Rushton W, Beuhler M, Shaker K, Aldy K, Campleman S, Wax P, Brent J, Ruha M; On behalf of the ToxIC North American Snakebite Study Group. Snake Bites in Diabetic Patients: A Descriptive Analysis. J Med Toxicol. 2022;18:97. View Abstract

4. Atti S, Farah R, Buehler M, Shaker K, Aldy K, Campleman S, Wax P, Brent J, Ruha AM; On behalf of the ToxIC North American Snakebite Study Group. A comparison of snakebite patients in those with and without diabetes. Clin Toxicol (Phila). 2022;60(S2):36. View Abstract

5. Burris O, Edric Wong, E, Dodson N, Rianprakaisang T; On behalf of the Toxicology Investigators Consortium (ToxIC). Review of Recent Herbicide Exposures. J Med Toxicol. 2022;18:104-105. View Abstract

6. Burris O, Wong E, Dodson N, Rianprakaisang T; On behalf of the Toxicology Investigators Consortium (ToxIC). Review of Recent Rodenticide Exposures. J Med Toxicol. 2022;18:105. View Abstract

7. Calello D, Jefri M, Nguyen T-A, Aldy K, Campleman S, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Identification of a Novel Opioid, N-piperidinyl etonitazene in Patients with Suspected Opioid Overdose. J Med Toxicol. 2022;18:109-110. View Abstract

8. Campleman SL, Li S, Aldy, K, Brent J, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Relative Frequency of Polydrug Exposures Involving Opioids and Sedative-Hypnotic Agents in the ToxIC Registry by Race/Ethnicity: 2015-2020.  J Med Toxicol. 2022;18:36. View Abstract

9. Chettat S, Stephani J, Hendrickson R; On behalf of the Toxicology Investigators Consortium (ToxIC). Drug And Toxicant-associated Rhabdomyolysis: Clinical and Epidemiologic Trends. J Med Toxicol. 2022;18:81-82. View Abstract

10. Cohen N, Mathew M, Brent J, Wax P, Davis A, Obilom C, Burns M, Canning J, Baumgartner K, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Severe outcomes following pediatric cannabis intoxications: a prospective cohort study of an international toxicology surveillance registry. Clin Toxicol (Phila). 2022;60(S2):42. View Abstract

11. Farah R, Kazzi Z, Brent J, Burkhart K, Wax P, Aldy K; On behalf of the ToxIC FACT Study Group. Ivermectin Associated Adverse Events in the Treatment and Prophylaxis of COVID-19 Reported to the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project Study Group. J Med Toxicol. 2022;18:79. View Abstract

12. Glidden E, Mustaquim D, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). Prescription stimulants combined with prescription or illicit opioid exposures within the Toxicology Investigators Consortium (ToxIC) Core Registry, January 2012–December 2021. Clin Toxicol (Phila). 2022;60(S2):76. View Abstract

13. Hughes A, Hendrickson R,  Aldy K, Campleman S, Meyn A, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Co-presence of Mitragynine and Fentanyl in Emergency Department Patients with Suspected Opioid Overdose. J Med Toxicol. 2022;18:87. View Abstract

14. Levine M, Aldy K, Meyn A, Campleman, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Prevalence Of Adulterants in Acute Opioid Toxic Patients. J Med Toxicol. 2022;18:76-77. View Abstract

15. Love J, Levine M, Aldy K, Brent J, Wax P, Krotulski A, Logan B, Vargas-Torres C, Manini A; On behalf of the ToxIC Fentalog Study Group. “Tranq dope” opioid overdose: clinical outcomes for emergency department patients with illicit opioid overdose adulterated with xylazine. Clin Toxicol (Phila). 2022;60(S2):7. View Abstract

16. Love J, Campleman S, Wax P, Brent J, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). Race, Ethnicity, and Age Distribution of Opioid Exposures Seen by Medical Toxicologists. J Med Toxicol. 2022;18:36-37. View Abstract

17. Magnusson K, Fikse D, Glidden E, Beauchamp G, Aldy K, Mustaquim D, Sabino J, Greenberg M, Amaducci A; On behalf of the Toxicology Investigators Consortium (ToxIC).  A five-year analysis of the Toxicology Investigators Consortium (ToxIC) core registry: descriptive differences among patients who identified as transgender compared to cisgender, 2017–2021. Clin Toxicol (Phila). 2022;60(S2):26. View Abstract

18. Olives T, Hendrickson A, Meyn A, Campleman S, Abston S, Wax P, Brent J, Aldy K; On behalf of the ToxIC FACT Study Group. Burden of Adverse Events Related to the Treatment of COVID19 by Race/Ethnicity. J Med Toxicol. 2022;18:82. View Abstract

19. Safa R, Liss D; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics and outcomes of bupropion overdose patients in the Toxicology Investigators Consortium (ToxIC) registry. Clin Toxicol (Phila). 2022;60(S2):31. View Abstract

20. Schwarz E, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Tramadulterant: Tramadol Detected in Patient’s Serum Following An Acute Opioid Overdose. J Med Toxicol. 2022;18:109. View Abstract

21. Schwarz E, Aldy K, Campleman S, Li S, Meyn A, Abston S, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Utilization of telehealth by medical toxicologists. Clin Toxicol (Phila). 2022;60(S2):123. View Abstract

22. Shastry S, Aldy K, Campleman S, Meyn A, Abston S, Krotulski A, Logan B, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Psychostimulant Drug Co-ingestion in Emergency Department Patients with Opioid Overdose: a Multi-Center ToxIC Collaboration. J Med Toxicol. 2022;18:108-109. View Abstract

23. Shastry S, Aldy K, Brent J, Wax P, Manini A; On behalf of the ToxIC Fentalog Study Group. Psychostimulant drug co-ingestion in emergency department patients with opioid overdose: A multi-center ToxIC Collaboration. Presented at the European Association of Poisons Centres and Clinical Toxicologists 2022, Tallinn, Estonia. Clin Toxicol (Phila). 2022; 60 (S1):35-36. View Abstract

24. Simon M, Heard K; On behalf of the Toxicology Investigators Consortium (ToxIC). Antimuscarinic or Asleep: A Comparison of Antimuscarinic Effects Between Hydroxyzine and Diphenhydramine Poisoned Patients. J Med Toxicol. 2022;18:112-113. View Abstract

25. Simon M, Buchanan J, Brent J, Wax P, Burkhart K, Aldy K; On behalf of the ToxIC FACT Study Group. Pregnancy associated adverse events in patients treated with therapies for COVID-19 reported to the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance project. Clin Toxicol (Phila). 2022;60(S2):18. View Abstract

26. Spyres M, Campleman S, Li S, Wax P, Brent J, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric opioid toxicity secondary to buprenorphine: a review of cases reported to the ToxIC Registry 2010–2021. Clin Toxicol (Phila). 2022;60(S2):83. View Abstract

27. Wong E, Rianprakaisang T; On behalf of the Toxicology Investigators Consortium (ToxIC). Direct oral anticoagulant ingestions: a review of the Toxicology Investigators Consortium Registry (ToxIC). Clin Toxicol (Phila). 2022;60(S2):39. View Abstract

2021

1. Aldy K, Wax P, Brent J, Marshall S, Campleman S, Abston S, Meyn A, Diak IL, Konkel K, Mundkur M, Dang O, Burkhart K; On behalf of the ToxIC FACT Study Group. Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics. Clin Toxicol (Phila). 2021;59(11):1054. View Abstract

2. Amaducci A, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Hughes A, Pizon A, Shulman J, Schwarz E, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Clonazolam and Fentanyl: What’s in Your Local Drug Supply? Clin Toxicol (Phila). 2021;59(11):1061-1062. View Abstract

3. Amaducci A, Aldy K, Campleman S, Li S, Meyn A, Abston S, Spyres MB, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Toxicological Exposures in COVID-19 Patients. Clin Toxicol (Phila). 2021;59(11):1159-1160. View Abstract

4. Basse J, Greene S, Ruha AM, Baumgartner K, Mullins M, Wax P, Brent J, Campleman S, Schwarz E; On behalf of the ToxIC Snakebite Study Group. Clinical Presentations, Treatments, and Outcomes of Exotic Snake Envenomations in the United States. J Med Toxicol. 2021;17:100-101. View Abstract

5. Camarena-Michel A, Martinez AE, Hoyte C; On behalf of the Toxicology Investigators Consortium (ToxIC). Access to opioid treatment facilities in opioid overdose patients by race and ethnicity on behalf of the ACMT Toxicology Investigators Consortium (ToxIC). Clin Toxicol (Phila). 2021;59(11):1081-1082. View Abstract

6. Carey J, Babu K, Merchant R; On behalf of the Toxicology Investigators Consortium (ToxIC). Does hepatotoxicity occur more frequently among American Indians/ Alaskan natives after acetaminophen overdose? Clin Toxicol (Phila). 2021;59(11):1149-1150. View Abstract

7. Carey JL, Boyle KL, Aldy K, Campleman S, Abston S, Meyn A, Wax P, Brent J; On behalf of the ToxIC FACT Study Group. Adverse Drug Events Associated with Monoclonal Antibodies Used in the Treatment of COVID-19. Clin Toxicol (Phila). 2021;59(11):1053-1054. View Abstract

8. Cohen N, Mathew M, Davis A, Brent J, Wax P, Schuh S, Freedman SB, Froberg BA, Schwarz E, Canning J, Tortora L, Hoyte C, Koons A, Burns MM, McFalls J, Weigand TJ, Hendrickson RG, Judge B, Quang LS, Hodgman M, Chenoweth JA, Algren DA, Carey J, Caravati EM, Akpunonu P, Geib AJ, Seifert SA, Kazzi Z, Othong R, Greene SC, Holstege C, Tweet MS, Vearrier D, Pizon A, Aldy K, Campleman SL, Li S, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Predictors of severe outcome following opioid overdose in children: a case-control study of a prospective toxicology surveillance registry. Clin Toxicol (Phila). 2021;59(11):1172. View Abstract

9. Devgun J, Aldy K, Campleman S, Abston S, Meyn A, Brent J, Wax P; On behalf of the ToxIC FACT Study Group. Remdesivir Associated Bradycardia Identified through the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project. Clin Toxicol (Phila). 2021; 59(11):1052. View Abstract

10. Dodson N, Wong E, Rianprakaisang T; On behalf of the Toxicology Investigators Consortium (ToxIC). Comparing clinical features of benzodiazepine overdoses: a review of the Toxicology Investigators Consortium registry. Clin Toxicol (Phila). 2021;59(11):1115-1116. View Abstract

11. Filip A, Berg S, Mullins M, Schwarz E; On behalf of the Toxicology Investigators Consortium (ToxIC). Fomepizole As An Adjunctive Therapy For Acetaminophen Poisoning: Cases Reported To The Toxicology Investigators Consortium (ToxIC) Database 2015-2020. J Med Toxicol. 2021;17:96. View Abstract

12. Hack K, Mazer-Amirshahi M, Campleman S, Karshenas D, Pizon A; On behalf of the Toxicology Investigators Consortium (ToxIC). Observations Impacting Pregnancy in the ToxIC Registry. J Med Toxicol. 2021;17:142–143. View Abstract

13. Hughes A, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Amaducci A, Pizon A, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Designer benzodiazepines etizolam and flubromazolam detected in patients with suspected opioid overdose. Clin Toxicol (Phila). 2021;59(11):1047-1048. View Abstract

14. Kaiser S, Rague J, Smith K, Weiss S; On behalf of the Toxicology Investigators Consortium (ToxIC). A secondary analysis of adverse events and naloxone administration in intentional kratom exposures from 2013 – 2020 using the Toxicology Investigators Consortium (ToxIC) registry. Clin Toxicol (Phila). 2021;59(11):1130-1131. View Abstract

15. Lavonas EJ, Dalton AM, Olson R, Rapp-Olsson M, Reynolds K, Ruha AM, Campleman S, Aldy K, Dart RC; On behalf of the ToxIC Snakebite Study Group. Most Rattlesnake Envenomation Patients Receive Multiple Doses of Antivenom. Annals of Emergency Medicine; 2021;78(4):S30-S31. View Abstract

16. Lavonas EJ, Rapp-Olsson M, Dalton AM, Reynolds AM, Dart RC; On behalf of the Toxicology Investigators Consortium (ToxIC). Most Rattlesnake Envenomation Patients Receive Multiple Doses of Antivenom. Acad Emerg Med. 2021;28(Suppl. 1):S86. View Abstract

17. Levine M, Aldy K, Meyn A, Campleman S, Krotulski A, Logan B, Hughes A, Schwarz E, Pizon A, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Adulteration of Illicit Drugs in ED Patients with Acute Opioid Overdose: A Multicenter Cohort. Clin Toxicol (Phila). 2021;59(11):1067. View Abstract

18. Levine M, Meyn A, Krotulski A, Logan B, Amaducci A, Hughes A, Schwarz E, Pizon A, Wax P, Brent J, Manini A; On behalf of the ToxIC Fentalog Study Group. Adulteration of Illicit Drugs in ED Patients with Acute Opioid Overdose: A Multicenter Cohort. Ann Emerg Med. 2021;78(4S):S29. View Abstract

19. Lewis B, Judge B; On behalf of the Toxicology Investigators Consortium (ToxIC). Gastrointestinal Decontamination: Trends from the ToxIC Case Registry, A Five-Year Review. J Med Toxicol. 2021;17:144. View Abstract

20. Love J, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). Fatality Trends Using the Toxicology Investigator’s Consortium (ToxIC) Registry: A 6-year Review of Demographics and Clinical Characteristics. J Med Toxicol. 2021;17:143. View Abstract

21. Love J, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). Treatment Modality Trends in Fatalities Reported to the Toxicology Investigator’s Consortium (ToxIC) Registry: A Six Year Review. J Med Toxicol. 2021;17:143-144. View Abstract

22. Manini AF, Krotulski A, Allen LR, Brent J, Samame V, Vidal K, Wax P, Logan B; On behalf of the Toxicology Investigators Consortium (ToxIC).  Fentanyl and fentanyl analogues in emergency department patients with suspected heroin overdose in the pre-COVID- 19 era. Acad Emerg Med. 2021;28(Suppl. 1):S85. View Abstract

23. Nguyen H, Amaducci A, Hoyte C; On behalf of the Toxicology Investigators Consortium (ToxIC). Toxicologic exposures in transgender patients during the SARS- CoV2 pandemic. Clin Toxicol (Phila). 2021;59(11):1071. View Abstract

24. Obilom C, McFalls J, Epperson L, Shaker K, Brent J, Wax P, Aldy K; On behalf of the Toxicology Investigators Consortium (ToxIC). A Look Back: E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) Before and After the COVID-19 Pandemic. J Med Toxicol. 2021;17:99. View Abstract

25. Pitotti C, Kaplan S, Ruha AM, Wolk B, Hoyte C; On behalf of the ToxIC Snakebite Study Group. Characterization of F(ab’)2 and Fab crotalidae antivenom single and combination therapy 2018-2020: retrospective analysis of the North American Snakebite Registry. Clin Toxicol (Phila). 2021;59(11):1038-1039. View Abstract

26. Schwarz E, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Clinical effects and treatment of patients following overdoses of brorphine and butyrylfentanyl. Clin Toxicol (Phila). 2021;59(11):1060. View Abstract

27. Schwarz ES, Spyres MB, Aldy K, Campleman S, Li S, Meyn A, Abston S, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Teletoxicology in the time of COVID. Clin Toxicol (Phila). 2021;59(11):1138-1139. View Abstract

28. Simon M, Heard K; On behalf of the Toxicology Investigators Consortium (ToxIC). All antihistamines are not the same: a comparison of antimuscarinic effects between hydroxyzine and diphenhydramine poisoned patients. Clin Toxicol (Phila). 2021;59(11):1103. View Abstract

29. Spyres M, Makar G, Meadors K, Ruha AM; On behalf of the ToxIC Snakebite Study Group. Compartment syndrome and rattlesnake envenomation: a review of the NASBR subregistry 2013-2020. Clin Toxicol (Phila). 2021;59(11):1123. View Abstract

30. Spyres M, Padilla G, Gerkin R, Ruha AM; On behalf of the ToxIC Snakebite Study Group. Late hemotoxicity following North American rattlesnake envenomation treated with Crotalidae immune F(ab’)2 (equine) antivenom (Anavip®).  J Med Toxicol. 2021;17:94. View Abstract

31. Wax PM, Aldy K, Brent J; On behalf of the ToxIC FACT Study Group; Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics. Toxicol Lett. 2021;350:S20. View Abstract

32. Wong E, Dodson N, Rianprakaisang; On behalf of the Toxicology Investigators Consortium (ToxIC). Comparing clinical features of benzodiazepine and z-drug overdoses: a review of the Toxicology Investigators Consortium registry. Clin Toxicol (Phila). 2021;59(11):1095. View Abstract

2020

1. Aldy KN, Cao D, Billington M, McFalls J, Obilom C, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Effect of Diagnostic Findings on Treatment and Patient Outcome in E-cigarette, or Vaping, Product Use Associated Lung Injury (EVALI). J Med Toxicol. 2020;16:75-86. View Abstract

2. Aldy KN, Cao D, Billington M, McFalls J, Obilom C, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Effects of Patient and Use Characteristics on Symptoms and Outcome in E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI). J Med Toxicol. 2020;16:75-86. View Abstract

3. Aldy KN, Cao D, Wax P, Brent J, Calello D, Campleman S; On behalf of the Toxicology Investigators Consortium (ToxIC). Establishing a Rapid Surveillance Response for E-cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) Using the ToxIC Registry. J Med Toxicol. 2020;16:75-86. View Abstract

4. Baumgartner KT, Schwarz ES; On behalf of the Toxicology Investigators Consortium (ToxIC). Treatment of Beta Blocker and Calcium Channel Antagonist Poisoning by Medical Toxicologists. J Med Toxicol. 2020;16:75-86. View Abstract

5. Billington MER, Aldy K, Wax P, Cao DJ; On behalf of the Toxicology Investigators Consortium (ToxIC). Steroid Statistics: a Regional Review of the Use of Systemic Steroids in the Treatment of Electronic Vaping-Associated Lung Injuries (EVALI). J Med Toxicol. 2020;16:75-86. View Abstract

6. Brent J; On behalf of the the ACMT Toxicology Investigators Consortium (ToxIC). Lack of Predictive Value of Provoked Urine Test Results in the Determination of Toxic Exposures. J Med Toxicol. 2020;16:75-86. View Abstract

7. Calello DP, Aldy K, Campleman S, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Management Trends in the Toxicology Investigators Consortium Registry: a 10-Year Review. J Med Toxicol. 2020;16:75-86. View Abstract

8. Campleman S, Li S, Brent J, Calello D, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Ten-Year Trends in Reporting of Methamphetamine and Heroin Exposure as Treated by Medical Toxicologists: 2010–2019. J Med Toxicol. 2020;16:75-86. View Abstract

9. Chen RJ, Ershad M, Campleman S, Vearrier D; On behalf of the Toxicology Investigators Consortium (ToxIC). Epidemiology and Treatment of Z-Drug Toxicity as Reported by Medical Toxicologists: a ToxIC Database Study. J Med Toxicol. 2020;16:75-86. View Abstract

10. Daigh AW, Varney SM, Huang M, Gelfond JA, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Dantrolene Sodium in Neuroleptic Malignant Syndrome: Is There a Benefit? J Med Toxicol. 2020;16:75-86. View Abstract

11. Fishburn SJ, Schwarz ES; On behalf of the Toxicology Investigators Consortium (ToxIC). Characterizing Occupational and Environmental Exposures inthe ACMT Toxicology Investigators Consortium Database. J Med Toxicol. 2020;16:75-86. View Abstract

12. Friedman N; On behalf of the Toxicology Investigators Consortium (ToxIC). Fatalities in Poisoned Patients Managed by Medical Toxicologists. J Med Toxicol. 2020;16:75-86. View Abstract

13. Hurwitz MB, McWhirter CR, Laubach LT, Beauchamp GA, Sabino JN, Careyva BA, Cook MD, Greenberg MR, Cannon RD, Surmaitis RM; On behalf of the Toxicology Investigators Consortium (ToxIC). Agents of Exposure in Transgender Patient Cases Managed by a Toxicologist: an Analysis of the Toxicology Investigator’s Consortium (ToxIC) Registry. J Med Toxicol. 2020;16:75-86. View Abstract

14. Greene S, Ruha AM, Brent J, Campleman S, Wax P; On behalf of the ToxIC Snakebite Study Group. Epidemiology, Clinical Features, and Management of Texas Coral Snake (Micrurus tener) Envenomations Reported to the North American Snakebite Registry. Clin Toxicol (Phila). 2020;58(11):1136. View Abstract

15. Manini AF, Brent J, Campleman S, Judge BS, Kao L, Loo G, Pizon AF, Ruha A, Wiegand T, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Validation of a Prediction Rule for Adverse Cardiovascular Events from Drug Overdose. Ann Emerg Med. 2020;76(4S):S6. View Abstract

16. Pizon AF, Wax P, Campleman S, Karshenas D, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Quality Measures for Medical Toxicology Patients: an 18-Month Update. J Med Toxicol. 2020;16:75-86. View Abstract

17. Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Quality Performance Measures in Medical Toxicology. J Med Toxicol. 2020;16:75-86. View Abstract

2019

1. Barbuto A, Chary M, Burns M; On behalf of the Toxicology Investigators Consortium (ToxIC). Octreotide Use By Medical Toxicologiests: An Analysis from the ToxIC Registry. J Med Toxicol. 2019;15:85. View Abstract

2. Camarena-Michel A, Hatten B; On behalf of the Toxicology Investigators Consortium (ToxIC). Racial and Ethnic Patterns of Intentional Overdose. J Med Toxicol. 2019;15:63. View Abstract

3. Campleman S, Wax P, Pizon A, Karshenas D, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Screening for Risk of Opioid Misuse and Overuse by Medical Toxicologists. J Med Toxicol. 2019;15:89. View Abstract

4. Carreiro S, Miller S, Wang B, Wax P, Campleman S, Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC). Clinical Predictors of Adverse Cardiocascular Events for Acute Pediatric Drug Exposures. J Med Toxicol. 2019;15:87. View Abstract

5. Hughes A, Blumenberg A, Murphy L, Rianprakaisang T, Hendrickson R; On behalf of the Toxicology Investigators Consortium (ToxIC). Predictors of Poisoning Severity in Diphenhydramine Overdose. J Med Toxicol. 2019;15:74. View Abstract

6. Mazer-Amirshahi M, Riederer A, Campleman S, Calello D, Burkhart K, Brent J, Wax P; On behalf of the Toxicology Investigators Consortium (ToxIC). Increasing Misuse and Abuse of Gabapentin and Pregabalin.  J Med Toxicol. 2019;15:75. View Abstract

7. Murray B, Carpenter J, Dunkley C, Moran T, Alsukaiti W, Alfaifi M, Kazzi Z; On behalf of the Toxicology Investigators Consortium (ToxIC). Single Agent Bupropion Overdose: Effects as Reported in the ToxIC Registry.  J Med Toxicol. 2019;15:60. View Abstract

8. Pizon A, Wax P, Campleman S, Karshenas D, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Implementing a Quality Measure Performance Program for Medical Toxicology Patients.  J Med Toxicol. 2019;15:95. View Abstract

9. Rianprakaisang T, Prather C, Blumenberg A, Murphy L, Hughes A, Hendrickson R; On behalf of the Toxicology Investigators Consortium (ToxIC). Does Co-Ingestion with Benzodiazepines Reduce the Rate of Seizures in Overdose? A Review of the Toxicology Investigators Consortium Database.  J Med Toxicol. 2019, 15:61. View Abstract

10. Rianprakaisang T, Prather C, Murphy L, Blumenberg A, Hughes A, Hendrickson R; On behalf of the Toxicology Investigators Consortium (ToxIC). Rates of Serotonin Toxicity and Factors Associated with Seizures in SNRI Overdose: A Review of the Toxicology Investigators Consortium Database. J Med Toxicol. 2019;15:86. View Abstract

11. Spyres M, Mazer-Amirshahi M, Riederer A, Campleman S, Wax, P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Utilizing the ToxIC Network to Assess the Impact of Opioid and Benzodiazepine Misuse/Abuse on Older Adults.  J Med Toxicol. 2019;15:87. View Abstract

12. Wax P, Pizon A, Campleman S, Karshenas D, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). ECG Assessment in Acute Overdose. J Med Toxicol. 2019;15:96. View Abstract

13. Wax P, Pizon A, Campleman S, Karshenas D, Brent J; On behalf of with the Toxicology Investigators Consortium (ToxIC). Pregnancy Testing in Toxicological Evaluations. J Med Toxicol. 2019;15:96. View Abstract

2018

1. Beauchamp G, Carey J, Adams T, Colón M, Cook M, Cannon R, Katz K, Wier A, Rayl Greenberg M; On behalf of the Toxicology Investigators Consortium (ToxIC). Sex Differences in Poisonings Among Older Adults: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry: 2010–2016. J Med Toxicol. 2018;14:35. View Abstract

2. Beauchamp G, Carey J, Cook M, Cannon R, Katz K, Ely B, Pollack E, Mazzaccaro R, Rayl Greenberg M; On behalf of the Toxicology Investigators Consortium (ToxIC). Sex Differences in Pediatric Poisonings: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry: 2010–2016.  J Med Toxicol. 2018;14:60. View Abstract

3. Beauchamp G, Carey J, Tully B, Cook M, Cannon R, Katz K, Rayl Greenberg M; On behalf of the Toxicology Investigators Consortium (ToxIC). Sex Differences in Adult Abuse and Misuse Cases: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry: 2010–2016. J Med Toxicol. 2018;14:45. View Abstract

4. Beauchamp G, Greenberg MR, Meyers M, Cook M, Cannon R, Katz K, Amaducci A, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010–2016. J Med Toxicol. 2018;14:44-45. View Abstract

5. Bruccoleri R, Davey M, Spyres M, Manini A, Dela Cruz M, Burns M; On behalf of the Toxicology Investigators Consortium (ToxIC). Sodium Bicarbonate Therapy: Treatment Recommendations and Clinical Outcomes as Reported Through the ToxIC Registry. J Med Toxicol. 2018;14:52. View Abstract

6. Camarena-Michel A, Hatten B; On behalf of the Toxicology Investigators Consortium (ToxIC). Racial and ethnic characteristics in cases of intentional pharmaceutical exposure with concern for toxicity. Clin Toxicol (Phila). 2018;56:520-521. View Abstract

7. Camarena-Michel A, Hoyte C; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics of Corticosteroid Use Across Various Toxic Exposures. J Med Toxicol. 2018;14:34. View Abstract

8. Camarena-Michel A, Hoyte C; On behalf of the Toxicology Investigators Consortium (ToxIC). The Frequency of Seizures After Exposure in Cases with QRS Interval Prolongation. J Med Toxicol. 2018;14:33. View Abstract

9. Campleman S, Wax P, Brent J, Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC). Drug-Specific Risk of Severe QT Prolongation Following Acute Drug Overdose.  J Med Toxicol. 2018;14:32. View Abstract

10. Gilley M, Brent J, Calello D, Wax P, Finkelstein Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Synthetic Cannabinoid Exposure in Adolescents Presenting for Emergency Care.  J Med Toxicol. 2018;14:18. View Abstract

11. King J, Rege S, Murphy C, Hatten B, Haynes A; On behalf of the Toxicology Investigators Consortium (ToxIC). ToxIC Extracorporeal Therapies SubRegistry: Update 2017.  J Med Toxicol. 2018;14:54. View Abstract

12. Moss M, Hendrickson R; On behalf of the Toxicology Investigators Consortium (ToxIC). Serotonin Toxicity Case Characteristics and Associated Xenobiotics: a Review of the Toxicology Investigators Consortium (ToxIC) Database.  J Med Toxicol. 2018;14:40. View Abstract

13. Noori M, Hendrickson R, Hatten B; On behalf of the Toxicology Investigators Consortium (ToxIC). Kratom: natural painkiller or herbal enemy? Clin Toxicol (Phila). 2018;56:574. View Abstract

14. Rianprakaisang T, Hendrickson R; On behalf of the Toxicology Investigators Consortium (ToxIC). Factors Associated with Seizures in Bupropion Overdose: a 3-Year Review of the ToxIC Registry. J Med Toxicol. 2018;14:23. View Abstract

15. Ruha AM, Gerkin R, Wolk B, Caravati E, Brent J, Campleman S, Wax P; On behalf of the ToxIC Snakebite Study Group. Association Between Initial Platelet Count and Antivenom Dose Following Rattlesnake Envenomation. J Med Toxicol. 2018;14:46. View Abstract

16. Shafer S, Campleman S, Haynes A, Callelo D, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Characteristics of Toxic Exposures in HIV-Positive Patients Reported to the Toxicology Investigators Consortium. J Med Toxicol. 2018;14:36. View Abstract

17. Spyres M, Choi Y; On behalf of the Toxicology Investigators Consortium (ToxIC). Fentanyl Exposures: The ToxIC Experience 2010–2017. J Med Toxicol. 2018;14:5. View Abstract

2017

1. Anderson SA, Dayan P, Calello D, Monte A, Oprescu A, Hurd Y , Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC). Increased Severity of Neuropsychiatric Outcomes with Acute Synthetic Cannabinoid Toxicity as Compared to Marijuana in Adolescents Presenting to Emergency Departments. J Med Toxicol. 2017;13:41-42. View Abstract

2. Campleman S, Wax P, Calello D, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Seven-year trends in the reporting of multiple agent exposures involving opioids and sedative-hypnotics/muscle relaxants to the ToxIC Registry, 2010-2016. Clin Toxicol (Phila). 2017;55(7):763. View Abstract

3. Campleman S, Riederer A, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Trends in the Occurrence of Opiate Exposure as Reported to the ToxIC Registry, 2010–2015. J Med Toxicol. 2017;13:38-39. View Abstract

4. Hatten B; On behalf of the Toxicology Investigators Consortium (ToxIC). Hydrogen Peroxide Exposures Reported to the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2017;13:17-18. View Abstract

5. Khalid MM, McCloskey, Vearrier D; On behalf of the Toxicology Investigators Consortium (ToxIC). Mushroom exposures in the United States reported to the Toxicology Investigator’s Consortium (ToxIC) registry. Clin Toxicol (Phila). 201;55(7):779. View Abstract

6. Kleinschmidt K, Ruha A, Wax P, Brent J, Campleman S; On behalf of the ToxIC Snakebite Study Group. Acute Adverse Events Associated With The Administration of FabAV Within The North American Snakebite Registry. J Med Toxicol. 2017;3:4. View Abstract

7. Lee V, Vera A, Calello D, Ruck B, Nelson L, Campleman S, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Loperamide misuse to avoid opioid withdrawal: High doses, high risk. Clin Toxicol (Phila). 2017;55(7):781. View Abstract

8. Levine M, Ruha M, Vohra R, Wolk B, Spyres M, Brent J, Wax P, Campleman S; On behalf of the ToxIC Snakebite Study Group. Comparison Of Pediatric Vs. Adult Rattlesnake Envenomations: The ToxIC Experience. J Med Toxicol. 2017;13:13. View Abstract

9. McCloskey K, Surmaitis R, Goldberger D, McKeever R; On behalf of the Toxicology Investigators Consortium (ToxIC). Characterizing benzodiazepine toxicities using the Toxicology Investigator’s Consortium (ToxIC) Registry. Clin Toxicol (Phila). 2017;55(3):495. View Abstract

10. Rianprakaisang T, Farrugia L, Rhyee S; On behalf of the Toxicology Investigators Consortium (ToxIC). Citalopram Ingestions: a Two Year Retrospective Study of the Toxicology Investigators Consortium. J Med Toxicol. 2017;13:7. View Abstract

11. Ruha A, Kleinschmidt K, Greene S, Spyres M, Wax P, Brent J, Padilla-Jones A, Campleman S; On behalf of the ToxIC Snakebite Study Group. The Epidemiologic and Clinical Characteristics of Snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13:4-5. View Abstract

12. Spyres M, Ruha A-M, Finkelstein Y, Levine M, Campleman; On behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric marijuana ingestions: the ToxIC experience 2010-2016. Clin Toxicol (Phila). 2017;55(7):798. View Abstract

13. Surmaitis R, McCloskey K, Goldberger D, Vearrier D; On behalf of the Toxicology Investigators Consortium (ToxIC). Characterizing the administration of fomepizole by medical toxicologists. Clin Toxicol (Phila). 2017;55(3):393. View Abstract

14. Vo T, Hendrickson R, Hatten B; On behalf of the Toxicology Investigators Consortium (ToxIC). Plant and fungi exposures reported to the Toxicology Investigator’s Consortium (ToxIC). Clin Toxicol (Phila). 2017;55(7):755. View Abstract

2016

1. Beauchamp GA, Hendrickson RG, Hatten BW. Endotracheal Intubation for Toxicologic Exposures: a Retrospective Review of Toxicology Investigators Consortium (ToxIC) Cases. J Med Toxicol. 2016;12(1):41. View Abstract

2. Boroughf W, Bedi DS, Hayoun MA, Walsh SJ. Elder Toxicology: Characterizing Intentional Pharmaceutical Exposures in the Aged Population Using the ToxIC Registry. J Med Toxicol. 2016;12(1):40. View Abstract

3. Boroughf W, Bedi DS, Hayoun MA, Walsh SJ. Elder Toxicology: Characterizing Unintentional Pharmaceutical Exposures in the Aged Population Using the ToxIC Registry. J Med Toxicol. 2016;12(1):40-41. View Abstract

4. Bruccoleri RE, Davey M, Spyres MB, Burns MM. Current Treatment Recommendations and Clinical Outcomes of Sodium Bicarbonate Therapy on Sodium Channel Blocking Agents through the ToxIC Registry.  J Med Toxicol. 2016;12(1):39. View Abstract

5. Campleman S, Wax P, Brent J. Improving Sentinel Reporting in a Medical Toxicology Surveillance System by Strengthening Data Entry Requirements.  J Med Toxicol. 2016;12(1):37. View Abstract

6. Campleman S, Wax P, Brent J. Opiate and Sedative-Hypnotics/Muscle Relaxants: Trends in Two Important Drug Classes as Reported to the ToxIC Registry, 2010–2014.  J Med Toxicol. 2016;12(1):38. View Abstract

7. Campleman S, Wax P, Brent J. The Toxicology Investigator’s Consortium Registry: Descriptive Analysis of the First 5 Years 2010–2014.  J Med Toxicol. 2016;12(1):37-38. View Abstract

8. Darracq MA, Vohra R, Ruha AM. Cutting to the Chase: Observations on Debridement in Crotalid Envenomation. ACMT ToxIC North American Snakebite Registry.  J Med Toxicol. 2016;12(1):35. View Abstract

9. Fernandez D, NelsonLS, Repplinger DJ, Smith SW. Metformin Intentional Overdose and its Association with Metabolic Acidosis and Elevated Lactate—As Reported by Toxicologists. J Med Toxicol. 2016;12(1):31-32. View Abstract

10. Ho J, Wax P, Leikin JB, Archer JRH, Wood DM, Dargan PI, Brent J. Metal-on-metal hip joint prostheses: a retrospective case series investigating association of systemic toxicity with serum cobalt and chromium concentrations. Clin Toxicol (Phila). 2016;54(4):430. View Abstract

11. Levine M, Brent J, Wax P, Macdonald E, Wiegand T, Vearrier D, McKeever R, Leikin JB, Ganetsky M, Beuhler M, Stellpflug SJ, Ruha AM, Spyres M, Carey J, Geib AJ, Engebretsen KM, Cao D, Kleinschmidt K, Vohra R, Riley BD; On behalf of the Lipid Emulsion Therapy Study Group. Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically Ill Poisoned Patients.  J Med Toxicol. 2016;12(1):4. View Abstract

12. Moore EC, Vohra V, Wolk B, Ruha AM. Snakebite Neurotoxicity: a Retrospective Review of Patients Reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2016;12(1):19. View Abstract

13. Othong R, Kazzi ZN. Descriptive study of medical toxicology consultations at a teaching university hospital in Bangkok. Clin Toxicol (Phila). 2016;54(4):456. View Abstract

14. Rickner SS, Cao D, Kleinschmidt KC. Assessment of Patterns of Substance Abuse among Adolescents and the Associated Severity of Outcome: a 5-Year Retrospective Cohort Study.  J Med Toxicol. 2016;12(1):16. View Abstract

2015

1. Abar B, Derienzo V, Conner K, Botelho S, Wiegand TJ. Intentional Pharmaceutical Overdoses Related to Therapeutic Misadventures: A Description of ToxIC Entries.  J Med Toxicol. 2015;11:7. View Abstract

2. Arroyo-Plasencia AM, Schwarz E. Street Drug Exposures in Hospitalized Patients as Reported to the Toxicology Investigators Consortium Case Registry. Clin Toxicol (Phila). 2015;53(7):697. View Abstract

3. Boyle KL, Farrugia LA, Carey JL. Characterization of Acute Opioid Overdose in the ToxIC Registry.  J Med Toxicol. 2015;11:11. View Abstract

4. Boyle KL, Arrugia LA, Carey JL. Characterization of acute opioid overdose in the ToxIC Registry. Clin Toxicol (Phila). 2015;53:378. View Abstract

5. Bruccoleri RE, Burns MM. Characteristics and Treatments of Patients with ECG Findings Significant for QRS Widening. J Med Toxicol. 2015;11:11. View Abstract

6. Calello DP, Troncoso AB, Geib AJ. Bupropion: An Atypical Cause of Serotonin Syndrome Report from the ToxIC Registry. J Med Toxicol. 2015;11:12. View Abstract

7. Calello DP, Troncoso AB. Features of Synthetic Cannabinoid Exposures: Report from the ToxIC Registry. J Med Toxicol. 2015;11:12-13. View Abstract

8. Calello DP, Shih RD, Troncoso AB. Respiratory depression and ventilatory support in synthetic cannabinoid exposures: Report from the ToxIC Registry. Clin Toxicol (Phila). 2015;53:366. View Abstract

9. Cao D, Wax P. Characterization of Single Substance Baclofen Exposure in the Toxicology Investigators Consortium Registry. Clin Toxicol (Phila). 2015;53(7):685. View Abstract

10. Conner KR, Abar B, Derienzo V, Ashrafioun L, Wiegand T. Characteristics of Intentional Self-Poisonings in Adolescents versus Adults in ToxIC Case Registry Entries. Clin Toxicol (Phila). 2015;53(7):715. View Abstract

11. Farrugia LA, Boyle KL, Carey JL. Suicidal Adolescents: Examining Self-Poisonings Within the Pediatric Population. J Med Toxicol. 2015;11:16-17. View Abstract

12. Farrugia LA , Boyle KL , Carey JL. Suicidal adolescents: Examining self-poisonings within the pediatric population. Clin Toxicol (Phila). 2015;53:293-294. View Abstract

13. Hatten BW, Beauchamp GA. Toxic exposures in young children resulting in tracheal intubation. Clin Toxicol (Phila). 2015;53:299. View Abstract

14. Hatten BW, Brent JA, Wax PM. Chemical Threat Agents Reported in the ToxIC Registry (2010-2013). J Med Toxicol. 2015;11:21. View Abstract

15. Levine M, Finkelstein Y, Rhyee SH, Vearrier DJ, Leikin JB, Beuhler MC. Antidotal Therapy by Intravenous Lipid Emulsion: Observations from the Toxicology Investigators Consortium (ToxIC).  J Med Toxicol. 2015;11:25. View Abstract

16. Onisko, NS, Kleinschmidt KC, Greene S, Bebarta V, Ruha AM, Padilla-Jones A. Characteristics of Acute Cottonmouth Envenomation from the ToxIC North American Snakebite Registry (NASBR). J Med Toxicol. 2015;11:32-33. View Abstract

17. Ruha AM, Kang AM, Onisko NS, Greene S, Vohra R, Seifert SA, Smith E, Padilla-Jones A. Antibiotic Use in the Management of Snake Envenomation. J Med Toxicol. 2015;11:36-37. View Abstract

18. Ruha AM, Spyres, MB, Kleinschmidt KC, Greene S, Vohra R, Smith E, Padilla-Jones A. Snakebite in the Elderly: A Retrospective Cohort of Patients Reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2015;11:37. View Abstract

19. Salib E, Derienzo V, Wiegand T. Unintentional Pediatric Opioid Exposures Reported to the ToxIC Case Registry. Clin Toxicol (Phila). 2015;53(7):741. View Abstract

20. Spyres MB, Ruha M, Wax P. Clinical and Demographic Factors in Marijuana Toxicity: The ToxIC Registry Experience since 2010.  Clin Toxicol (Phila). 2015;53(7):677. View Abstract

21. Stephani JA, Hendrickson RG. Single-Drug Exposures Associated with Rhabdomyolysis – A Review of the ToxIC Registry. J Med Toxicol. 2015;11:41. View Abstract

22. Varney SM, Wiegand TJ, Ramos RG, Brent J, Wax PM. A Descriptive Study of Prescription Opioid Misusers Evaluated by Medical Toxicologists.  J Med Toxicol. 2015;11:44. View Abstract

23. Wang GS, Levitan R, Wiegand T, Lowry J, Schult R, Yin S. Extracorporeal Membrane Oxygenation for Severe Toxicologic Exposures: Review of the Toxicology Investigators Consortium (ToxIC).  J Med Toxicol. 2015;11:45. View Abstract

24. Wax PM, Brent J, Campleman S. The Use of Insulin-Euglycemic Therapy by Medical Toxicologists.  J Med Toxicol. 2015;11:45. View Abstract

25. Wiegand TJ, Abar B, Derienzo V, Botelho S, Conner K. Intentional Pharmaceutical Overdoses: Comparison of Self-harm, Misuse/abuse and Therapeutic Misadventure ToxIC Case Registry Entries. J Med Toxicol. 2015;11:46. View Abstract

2014

1. Ahari S, O’Geen, R, Wiegand, TJ. Use of Multidose Activated Charcoal in the ToxIC Registry. J Med Toxicol. 2014;10:71. View Abstract

2. Cao JD, Bronstein AC, Lavonas EJ. Comparative analysis of exposure substances in the Toxicology Investigators Consortium case registry versus National Poison Data System. Clin Toxicol (Phila). 2014;52:783. View Abstract

3. Carey JL, Boyle KL, Rhyee S. Gender Differences In Prescription Medication Abuse. Acad Emerg Med. 2014;21(Suppl 1):S5-S348. View Abstract

4. Farmer BM, Nelson LS, Perrone J. Bedside Evaluation of Adverse Drug Events by Medical Toxicologists. J Med Toxicol. 2014;10:78-79. View Abstract

5. Farrugia LA, Rhyee SH. Characteristics of Patients Presenting to a Medical Toxicologist for Exposure to Heavy Metals. J Med Toxicol. 2014;10:79. View Abstract

6. Fil LF, Nelson LN , Olsen D. Naloxone Administration in the Pediatric Population According to ToxIC Database Reporting. J Med Toxicol. 2014;10:80. View Abstract

7. Finkelstein Y, Zelner I, Hutson JR, Matlow J, Koren G, Wax PM. Poisoning During Pregnancy: Observations from the Toxicology Investigators Consortium (ToxIC) Case Registry. J Med Toxicol. 2014;10:80. View Abstract

8. Hoyte C, Brent J. A characterization of cases of severe hyperthermia reported to the ToxIC Registry. Clin Toxicol (Phila). 2014;52:692. View Abstract

9. Kopec KT, Vohra R, Brusin K, Santos J, Otong R, Smith E, Brent J, Wax PM. The ToxIC International Registry: Initial Glimpses from Medical Toxicology Consultation Services in Russia, Thailand, and Mexico. J Med Toxicol. 2014;10:84-85. View Abstract

10. Laes J. Characterizing flumazenil use through utilization of a toxicology registry. Clin Toxicol (Phila). 2014;52:761-762. View Abstract

11. Levine M, Iwanicki J, Leikin JB, Donovan JW, McKay CA, Hernandez S, et al.; for the Management with Intravenous Lipid in Overdose (MILO) investigators. Intravenous Lipid Emulsion Therapy use in the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2014;10:85. View Abstract

12. McKeever RG, Sexton KJ, Vearrier D, Greenberg MI. Characteristics of salicylate ingestions reported to the toxic registry. Clin Toxicol (Phila). 2014;52:808. View Abstract

13. Onisko NS, Wax PM , Kleinschmidt KC. Non-APAP Containing Xenobiotics Associated with AST >1,000 U/L. J Med Toxicol. 2014;10:89. View Abstract

14. Ordonez J, Forrester MB, Wax PM, Kleinschmidt KC. A Comparative Study of Acetaminophen Exposures in ToxIC Registry with Texas Poison Center Data. J Med Toxicol. 2014;10:90. View Abstract

15. Ruha AM, Levitan R, Kleinschmidt KC, Vohra R, Smith E, Brent J, Wax PM. The ToxIC North American Snakebite Registry. J Med Toxicol. 2014;10:91. View Abstract

16. Troncoso A, Calello D. Pediatric laundry detergent pod exposures: Report from the Toxicology Investigator ’s Consortium (ToxIC registry). Clin Toxicol (Phila). 2014;52:723. View Abstract

17. Watkins JW, Schwarz E, Arroyo-Plasencia A, Mullins M. The differential use of physostigmine by toxicologists in anticholinergic toxicity based on causative agent. Clin Toxicol (Phila). 2014;52:753-754. View Abstract

18. Watkins JW, Schwarz EA, Arroyo-Plasencia AM. The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity. J Med Toxicol. 2014;10:70. View Abstract

2013

1. Hoyte C, Brent J. Cases of QT interval prolongation reported to the ToxIC (Toxicology Investigators Consortium) Registry. Clin Toxicol (Phila). 2013;51:656. View Abstract

2. Kopec K, Vohra R, Brusin K, Smith EA, Brent J, Wax P. Development of an international registry of poisoned patients using toxic. Clin Toxicol (Phila). 2013;51:631. View Abstract

3. Ordonez J, Kleinschmidt K, Wax P. Non-Ethanol hyperlipasemia in toxicology consultation. Clin Toxicol (Phila).2013;51:703. View Abstract

4. Schwartz T, Wax P, Wiegand T. The use of hemodialysis in medical toxicology practice: The ToxIC experience. Clin Toxicol (Phila). 2013;51:613. View Abstract

2012

1. Finkelstein Y, Hutson JR, Brent J, Wax PM. Drug-induced seizures in children presenting to the emergency department. Clin Toxicol (Phila). 2012;50:676. View Abstract

2. Hendrickson R, Witte D. Serotonin toxicity: Case characteristics and associated medications/drugs. Clin Toxicol (Phila). 2012;50:675. View Abstract

3. Hendrickson RG. Medications that are associated with serotonin toxicity: A review of the ToxIC Registry. Clin Toxicol (Phila). 2012;50(7):675. View Abstract

4. Obafemi AI, Wax P, Kleinschmidt K. Chelation therapy by medical toxicologists in the U.S. Clin Toxicol (Phila). 2012;50:664. View Abstract

5. Schwarz ES, Wax PM. Medical toxicology referrals in the acute care setting. Clin Toxicol (Phila). 2012;50;674. View Abstract

6. Vohra R, Kopec K, Brent J, Wax P, Gunja N. Pesticide poisonings reported to the ACMT Toxicology Investigators Consortium (ToxIC) Registry. APAMT Annual Meeting Proceedings. 2012. View Abstract

7. Zosel A, Ludtke H, Dille KS, Ippen C, Brent J. Characterizing herbals and dietary supplements toxicities using the Toxicology Investigators Consortium (ToxIC) registry. Clin Toxicol (Phila). 2012;50:659. View Abstract

2011

1. Kleinschmidt K, Wax P, Brent J. Comparison of Data in the Toxicology Investigators Consortium (ToxIC) Registry with the National Poison Data System (NPDS). Clin Toxicol (Phila). 2011;49(6):593. View Abstract

2. McKay C, Hart K. Hyperkalemia Does Not Predict Outcome From Digoxin Excess in Patients With Renal Dysfunction. Clin Toxicol (Phila). 2011;49(6):560. View Abstract

3. Smolcic E, Sachdeva K, Cresswell A, Donovan W, Rasimas J. Themes and Trends in Serious Intentional Self-Poisoning. Clin Toxicol (Phila). 2011;49(6):571. View Abstract

4. Wax P, Brent J. The Toxicology Investigators Consortium (ToxIC ) Registry: A National Registry of Patients Seen by Medical Toxicologists at the Bedside. EAPCCT Annual Meeting. Clin Toxicol (Phila). 2011;49(3):235. View Abstract

5. Wax P. Toxicology Investigator’s Consortium (ToxIC): Overview and Next Steps. J Med Toxicol. 2011;7:70. View Abstract

6. Wiegand T, Kamali M, Barton N, Wax P.  Alcohol intoxication, co-ingestion and withdrawal in Medical Toxicology consultations: a review of the ToxIC Case Registry. Clin Toxicol (Phila). 2011;49(6);531-532. View Abstract

2010

1. Kleinschmidt K, Wax P, Nelson L, Bird S, Brent J. The Toxicology Investigators Consortium (ToxIC) Registry – Establishing Its Viability. Clin Toxicol (Phila). 2010;48(6):651. View Abstract

2. Sharma K, Nelson L, Kurt K, Bird S, Brent J, Wax P. The Practice of Medical Toxicology in the US. Clin Toxicol (Phila). 2010;48(6):666-667. View Abstract

2009

1. Wax PM, Brent J. The Current Status of the Practice of Inpatient Medical Toxicology at the Bedside in the US. Clin Toxicol (Phila). 2009;47(7):740. View Abstract